SE430220B - SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF - Google Patents
SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOFInfo
- Publication number
- SE430220B SE430220B SE7900355A SE7900355A SE430220B SE 430220 B SE430220 B SE 430220B SE 7900355 A SE7900355 A SE 7900355A SE 7900355 A SE7900355 A SE 7900355A SE 430220 B SE430220 B SE 430220B
- Authority
- SE
- Sweden
- Prior art keywords
- catalyst
- parts
- mixture
- rhodium
- optically active
- Prior art date
Links
- 239000003054 catalyst Substances 0.000 title claims description 48
- 239000002253 acid Substances 0.000 title claims description 11
- 150000007513 acids Chemical class 0.000 title claims description 5
- 230000036571 hydration Effects 0.000 title description 2
- 238000006703 hydration reaction Methods 0.000 title description 2
- -1 rhodium coordination complex Chemical class 0.000 claims description 40
- 239000003446 ligand Substances 0.000 claims description 31
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 28
- 229910052703 rhodium Inorganic materials 0.000 claims description 18
- 239000010948 rhodium Substances 0.000 claims description 18
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 15
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 11
- ZMKOZQRDFHXOIH-UHFFFAOYSA-N cyclohexyl-[(2-methoxyphenyl)methyl]-methylphosphane Chemical compound COC1=CC=CC=C1CP(C)C1CCCCC1 ZMKOZQRDFHXOIH-UHFFFAOYSA-N 0.000 claims description 10
- 238000009876 asymmetric hydrogenation reaction Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000002091 cationic group Chemical group 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 150000001993 dienes Chemical class 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 79
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 67
- 239000000203 mixture Substances 0.000 description 45
- 239000000243 solution Substances 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 229910052751 metal Inorganic materials 0.000 description 26
- 239000002184 metal Substances 0.000 description 26
- 230000003287 optical effect Effects 0.000 description 26
- 238000005984 hydrogenation reaction Methods 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- 229910052739 hydrogen Inorganic materials 0.000 description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 239000001257 hydrogen Substances 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 125000001424 substituent group Chemical group 0.000 description 15
- RBFQJDQYXXHULB-UHFFFAOYSA-N arsane Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 10
- 229910052698 phosphorus Inorganic materials 0.000 description 10
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 10
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 9
- 239000012299 nitrogen atmosphere Substances 0.000 description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 239000011574 phosphorus Substances 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- 229910052785 arsenic Inorganic materials 0.000 description 7
- 239000007795 chemical reaction product Substances 0.000 description 7
- 150000002431 hydrogen Chemical group 0.000 description 7
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 6
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- WGHMKSPHCLPBTN-UHFFFAOYSA-N (2-methoxyphenyl)methyl-methyl-phenylphosphane Chemical compound COC1=CC=CC=C1CP(C)C1=CC=CC=C1 WGHMKSPHCLPBTN-UHFFFAOYSA-N 0.000 description 5
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 5
- 125000000217 alkyl group Chemical group 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000004696 coordination complex Chemical class 0.000 description 5
- 229910052741 iridium Inorganic materials 0.000 description 5
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 235000008729 phenylalanine Nutrition 0.000 description 5
- 229910052697 platinum Inorganic materials 0.000 description 5
- 229910052707 ruthenium Inorganic materials 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000004104 aryloxy group Chemical group 0.000 description 4
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzenecarboxaldehyde Natural products O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000000460 chlorine Chemical group 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- ZUYQAYFMISSPTF-UHFFFAOYSA-N methoxy-oxo-phenylphosphanium Chemical compound CO[P+](=O)C1=CC=CC=C1 ZUYQAYFMISSPTF-UHFFFAOYSA-N 0.000 description 4
- 229910052762 osmium Inorganic materials 0.000 description 4
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 3
- VFLJJPXIIVSKKP-UHFFFAOYSA-N 1-methoxy-2-[[methyl(phenyl)phosphoryl]methyl]benzene Chemical compound COC1=CC=CC=C1CP(C)(=O)C1=CC=CC=C1 VFLJJPXIIVSKKP-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229960003767 alanine Drugs 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 125000002541 furyl group Chemical group 0.000 description 3
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 229910052740 iodine Chemical group 0.000 description 3
- 239000011630 iodine Chemical group 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 150000002736 metal compounds Chemical class 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 3
- 229960005190 phenylalanine Drugs 0.000 description 3
- 150000002994 phenylalanines Chemical class 0.000 description 3
- 150000003003 phosphines Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000003283 rhodium Chemical class 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- ODTCNJWUFHCFJB-ZDUSSCGKSA-N (2s)-2-benzamido-3-(4-hydroxy-3-methoxyphenyl)propanoic acid Chemical compound C1=C(O)C(OC)=CC(C[C@H](NC(=O)C=2C=CC=CC=2)C(O)=O)=C1 ODTCNJWUFHCFJB-ZDUSSCGKSA-N 0.000 description 2
- IVWWFWFVSWOTLP-YVZVNANGSA-N (3'as,4r,7'as)-2,2,2',2'-tetramethylspiro[1,3-dioxolane-4,6'-4,7a-dihydro-3ah-[1,3]dioxolo[4,5-c]pyran]-7'-one Chemical compound C([C@@H]1OC(O[C@@H]1C1=O)(C)C)O[C@]21COC(C)(C)O2 IVWWFWFVSWOTLP-YVZVNANGSA-N 0.000 description 2
- HTDQSWDEWGSAMN-UHFFFAOYSA-N 1-bromo-2-methoxybenzene Chemical compound COC1=CC=CC=C1Br HTDQSWDEWGSAMN-UHFFFAOYSA-N 0.000 description 2
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 2
- IEJPPSMHUUQABK-UHFFFAOYSA-N 2,4-diphenyl-4h-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1C1=CC=CC=C1 IEJPPSMHUUQABK-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- SOMMFGSFLILBJJ-UHFFFAOYSA-N 2-acetamido-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid;acetic acid Chemical compound CC(O)=O.COC1=CC(C=C(NC(C)=O)C(O)=O)=CC=C1O SOMMFGSFLILBJJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- BOKLLMHOBIEELP-UHFFFAOYSA-N CCCP(=O)CC1=CC=CC=C1 Chemical compound CCCP(=O)CC1=CC=CC=C1 BOKLLMHOBIEELP-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000003935 benzaldehydes Chemical class 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- INANVXNIFVFBAR-UHFFFAOYSA-N benzyl(methyl)phosphinic acid Chemical compound CP(O)(=O)CC1=CC=CC=C1 INANVXNIFVFBAR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- LMZLQYYLELWCCW-UHFFFAOYSA-N dimethoxy(phenyl)phosphane Chemical compound COP(OC)C1=CC=CC=C1 LMZLQYYLELWCCW-UHFFFAOYSA-N 0.000 description 2
- 239000011737 fluorine Chemical group 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- YAAIIVCJIGGXCA-UHFFFAOYSA-N methyl-phenyl-propylarsane Chemical compound C[As](CCC)C1=CC=CC=C1 YAAIIVCJIGGXCA-UHFFFAOYSA-N 0.000 description 2
- UMLJLONQGFCDLO-UHFFFAOYSA-N methyl-phenyl-propylphosphane Chemical compound CCCP(C)C1=CC=CC=C1 UMLJLONQGFCDLO-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000003579 shift reagent Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 125000000547 substituted alkyl group Chemical group 0.000 description 2
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 2
- 239000005052 trichlorosilane Substances 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical group C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- XKBHPRKDNYAYEI-UHFFFAOYSA-N (2-methoxyphenyl)methylphosphane Chemical compound COC1=CC=CC=C1CP XKBHPRKDNYAYEI-UHFFFAOYSA-N 0.000 description 1
- NQKWPNDZHVCSKW-ZDUSSCGKSA-N (2s)-2-acetamido-3-(1-acetylindol-3-yl)propanoic acid Chemical compound C1=CC=C2C(C[C@H](NC(=O)C)C(O)=O)=CN(C(C)=O)C2=C1 NQKWPNDZHVCSKW-ZDUSSCGKSA-N 0.000 description 1
- SYTBZMRGLBWNTM-SNVBAGLBSA-N (R)-flurbiprofen Chemical compound FC1=CC([C@H](C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-SNVBAGLBSA-N 0.000 description 1
- VYXHVRARDIDEHS-UHFFFAOYSA-N 1,5-cyclooctadiene Chemical compound C1CC=CCCC=C1 VYXHVRARDIDEHS-UHFFFAOYSA-N 0.000 description 1
- 239000004912 1,5-cyclooctadiene Substances 0.000 description 1
- SGVUASDJMDTSKZ-UHFFFAOYSA-N 1-[[cyclohexyl(methyl)phosphoryl]methyl]-2-methoxybenzene Chemical compound COC1=CC=CC=C1CP(C)(=O)C1CCCCC1 SGVUASDJMDTSKZ-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- WSQYCAULLNISPN-UHFFFAOYSA-N 2-acetamido-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC(C=C(NC(C)=O)C(O)=O)=CC=C1O WSQYCAULLNISPN-UHFFFAOYSA-N 0.000 description 1
- SSYWXIPQHQHKGX-UHFFFAOYSA-N 2-benzamido-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound C1=C(O)C(OC)=CC(C=C(NC(=O)C=2C=CC=CC=2)C(O)=O)=C1 SSYWXIPQHQHKGX-UHFFFAOYSA-N 0.000 description 1
- KWCCJONWEMODEY-UHFFFAOYSA-N 2-methylpropyl(propan-2-yl)phosphane Chemical compound CC(C)CPC(C)C KWCCJONWEMODEY-UHFFFAOYSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- YZQCXOFQZKCETR-UWVGGRQHSA-N Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YZQCXOFQZKCETR-UWVGGRQHSA-N 0.000 description 1
- 241000726103 Atta Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- NIGWMJHCCYYCSF-UHFFFAOYSA-N Fenclonine Chemical compound OC(=O)C(N)CC1=CC=C(Cl)C=C1 NIGWMJHCCYYCSF-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- HARAJSLHEXQGPQ-UHFFFAOYSA-K [Cl-].C=CCCC=C.[Rh+3].[Cl-].[Cl-] Chemical compound [Cl-].C=CCCC=C.[Rh+3].[Cl-].[Cl-] HARAJSLHEXQGPQ-UHFFFAOYSA-K 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 150000001295 alanines Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- HIEDUWPOQBEHCE-UHFFFAOYSA-N benzyl-(2-methoxyphenyl)phosphane Chemical compound COC1=CC=CC=C1PCC1=CC=CC=C1 HIEDUWPOQBEHCE-UHFFFAOYSA-N 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- CPRXHCAKYVTPFP-UHFFFAOYSA-N butyl(ethyl)phosphane Chemical compound CCCCPCC CPRXHCAKYVTPFP-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- SLLGVCUQYRMELA-UHFFFAOYSA-N chlorosilicon Chemical compound Cl[Si] SLLGVCUQYRMELA-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IMDXZWRLUZPMDH-UHFFFAOYSA-N dichlorophenylphosphine Chemical compound ClP(Cl)C1=CC=CC=C1 IMDXZWRLUZPMDH-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- BXDCELKJGGVUHD-UHFFFAOYSA-N ethyl(methyl)phosphane Chemical compound CCPC BXDCELKJGGVUHD-UHFFFAOYSA-N 0.000 description 1
- ZNOXPPRACNEBIA-UHFFFAOYSA-N ethyl(phenyl)phosphane Chemical compound CCPC1=CC=CC=C1 ZNOXPPRACNEBIA-UHFFFAOYSA-N 0.000 description 1
- HIOLFROGDAUPLS-UHFFFAOYSA-N ethyl-(4-methylphenyl)-phenylphosphane Chemical compound C=1C=C(C)C=CC=1P(CC)C1=CC=CC=C1 HIOLFROGDAUPLS-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000002815 homogeneous catalyst Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- MHERPFVRWOTBSF-UHFFFAOYSA-N methyl(phenyl)phosphane Chemical compound CPC1=CC=CC=C1 MHERPFVRWOTBSF-UHFFFAOYSA-N 0.000 description 1
- JXGFKVWTMPAMLL-UHFFFAOYSA-N methyl(phenyl)phosphane;hydrochloride Chemical compound Cl.CPC1=CC=CC=C1 JXGFKVWTMPAMLL-UHFFFAOYSA-N 0.000 description 1
- ZCCDHRRDZKZPPO-UHFFFAOYSA-N methyl(propan-2-yl)phosphane Chemical compound CPC(C)C ZCCDHRRDZKZPPO-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- XRBCRPZXSCBRTK-UHFFFAOYSA-N phosphonous acid Chemical compound OPO XRBCRPZXSCBRTK-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003284 rhodium compounds Chemical class 0.000 description 1
- YWFDDXXMOPZFFM-UHFFFAOYSA-H rhodium(3+);trisulfate Chemical compound [Rh+3].[Rh+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O YWFDDXXMOPZFFM-UHFFFAOYSA-H 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001495 sodium tetrafluoroborate Inorganic materials 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- WMUVAMXULTVKIW-UHFFFAOYSA-K tribromorhodium;hydrate Chemical compound O.Br[Rh](Br)Br WMUVAMXULTVKIW-UHFFFAOYSA-K 0.000 description 1
- TYLYVJBCMQFRCB-UHFFFAOYSA-K trichlororhodium;trihydrate Chemical compound O.O.O.[Cl-].[Cl-].[Cl-].[Rh+3] TYLYVJBCMQFRCB-UHFFFAOYSA-K 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical group COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/18—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
- B01J31/1895—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms the ligands containing arsenic or antimony
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2291—Olefins
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/36—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/32—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/34—Halides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/66—Arsenic compounds
- C07F9/70—Organo-arsenic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/824—Palladium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/825—Osmium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/827—Iridium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/828—Platinum
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Hydrogen, Water And Hydrids (AREA)
Description
veøozss-4p e za 1op 15 20 25_ 50 55 utmärkta utbyten av den önskade enantiomeren erhålles ur dylika olefinföreningar,' om man som katalysator an- vänder en förening, som består av ett óptiskt aktivt metallkoordinationskomplex, som faller under struktur- formeln ralxnrš eller 1421:21? där M1 är roaium, rutenium, iridium eller osmium, M2 är palladium eller platina och X är väte, klor; fluor, brom eller jod, n är ett helt tal 1 eller 5, var och en av symbolerna L representerar en fosfin- eller arsinligand, av vilka minst en är op- tiskt aktiv. En sådan reaktion àskådliggöres i följande reaktionsschema, där fiksubstituenten är fenyl: aktiv _ Acyl katalysator Acyl - p orm -coofl i *_12 a GHz-CH-ooofii » IH opt1skt_ . . ¿%H Sådana förfaranden för asymmetrisk hydrering är fö- remål för det svenska patentet 7106040-4 (publmr. 400 552) och behandlas utförligt i dess beskrivning. fßsubstituenten kan exempelvis vara väte, alkyl, substituerad alkyl, aryl, substituerad aryl, aralkyl, amino, bensylamino, dibensylamino, nitro, karboxyl och karboxylester etc. Fackmannen på här ifrågavarande omrâde kan välja/6-substituenten ur ett stort antal grupper och man behöver vid detta val endast se till att den önskade aëaminosyran erhålles som slutprodukt. excellent yields of the desired enantiomer are obtained from such olefin compounds if a compound consisting of an optically active metal coordination complex falling under the structural formula ralxnrš or 1421 is used as the catalyst. : 21? where M1 is roaium, ruthenium, iridium or osmium, M2 is palladium or platinum and X is hydrogen, chlorine; fluorine, bromine or iodine, n is an integer 1 or 5, each of the symbols L representing a phosphine or arsine ligand, at least one of which is optically active. Such a reaction is illustrated in the following reaction scheme, in which the fi x substituent is phenyl: active Acyl catalyst Acyl - p orm -coo fl i * _12 a GHz-CH-ooo fi i »1H optlskt_. . ¿% H Such procedures for asymmetric hydrogenation are the subject of Swedish patent 7106040-4 (Publ. No. 400 552) and are discussed in detail in its description. The substituent may be, for example, hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, amino, benzylamino, dibenzylamino, nitro, carboxyl and carboxylic ester, etc. Those skilled in the art may select the β-substituent from a large number of groups and need in this selection only make sure that the desired amino acid is obtained as the end product.
Som exempel på.äêaminosyror, vilkas enantiomerer med katalysatorn enligt uppfinningen lätt kan framställas, kan nämnas alanin, p-klorfenylalanin, tryptofan, fenylalanin, 5~(5,4-dihydroxifenyl)-alanin, 5-hydroxitryptofan, lysin, histidin, tyrosin, leucin, glutamsyra och valin.Examples of amino acids whose enantiomers with the catalyst according to the invention can be easily prepared are alanine, p-chlorophenylalanine, tryptophan, phenylalanine, 5- (5,4-dihydroxyphenyl) -alanine, 5-hydroxytryptophan, lysine, histidine, tyrosine, leucine, glutamic acid and valine.
Acylgruppen kan vara substituerad eller osubstituerad och som exempel kan nämnas acetyl, bensoyl, formyl, propi- onyl, butyryl,toluyl, nitrobensoyl och andra acylvarianter, som användes som skyddsgrupper vid peptidsyntes etc.The acyl group may be substituted or unsubstituted and examples include acetyl, benzoyl, formyl, propionyl, butyryl, toluyl, nitrobenzoyl and other acyl variants used as protecting groups in peptide synthesis, etc.
Det föredrages att sådan katalytisk hydrering avfß- substituerad4Rëacylamido-akrylsyror genomföres i närvaro av en bas. /5-substituerade fiëacylamido-akrylsyror och/eller sal- 10 15 20 25 50 5 vsoosss-4 ter därav är förelöpare till de substituerade eller osub- stituerade alaninerna. c Föreningarna med nedanstående strukturformel ger ut- märkta resultat vid hydrering med katalysatorn enligt upp- finningen och representerar därför föreningar, som är spe- ciellt lämpliga för ändamålet: T - Q = P - COOH H hfi Z T representerar väte, karboxyl, osubstituerad eller sub- stituerad alkyl, tienyl, ßhindolyl, fbimidazolyl, furyl, píperenyl eller Bp c- Cq Dr och var och en av symbolerna B, C och D, den ena oberoen- de av den andra representerar väte, alkyl, karboxyl, hyd- roxyl (och metallsalter därav), alkoxi, halogen, acyloxi, aryloxi, aralkyloxi, amino, alkylamino, nitro eller cyan, Z representerar substituerad eller osubstituerad acyl av ovan angivet slag och p, q och r_är hela tal O-5, varvid summan p+q+r är högst 5.It is preferred that such catalytic hydrogenation of unsubstituted 4Reaacylamidoacrylic acids be carried out in the presence of a base. Β-substituted β-acylamido-acrylic acids and / or salts thereof are precursors to the substituted or unsubstituted alanines. The compounds of the following structural formula give excellent results in hydrogenation with the catalyst according to the invention and therefore represent compounds which are particularly suitable for the purpose: T - Q = P - COOH H h fi ZT represents hydrogen, carboxyl, unsubstituted or sub substituted alkyl, thienyl, β-indolyl, fbimidazolyl, furyl, piperenyl or Bp c- Cq Dr and each of the symbols B, C and D, one independently of the other, represents hydrogen, alkyl, carboxyl, hydroxyl ( and metal salts thereof), alkoxy, halogen, acyloxy, aryloxy, aralkyloxy, amino, alkylamino, nitro or cyano, Z represents substituted or unsubstituted acyl of the kind indicated above and p, q and r are the integer O-5, the sum p + q + r is at most 5.
En speciellt föredragen utföringsform, som också är belysande för hydrering med katalysatorn enligt uppfin- ningen, är framställningen av de substituerade och osub- stituerade fenylalaninerna genom katalytisk asymmetrisk hydrering. Omättade förelöpare för sådana Obaminosyror kan framställas enligt Erlenmeyers azlaktonsyntes, varvid en substituerad eller osubstituerad bensaldehyd omsättes med en acylglycin, exempelvis acetylglycin, och ättiksyra- anhydrid till azlakton, som hydrolyseras till den omättade förelöparen. En sådan reaktion belyses med följande reak- tionsschema, i vilket man använder bensaldehyd och acetyl- glycin som exempel på reaktionskomponenter: vanessa-n i ~ i o i o ll - Il .'“' (l) Q-CHO + CH5C-1\1H-CH2C0OH-+ O(C-CH3)2 --)<\:/>-CH=(,JT_(|)=O _ 'à V: cH 5 (2) Quinn-om .____.___+h3'dI-'°1YS i Q anala-coon nn N O _\l <2 <.==° CH; CH3 ¶ _'I sådana reaktioner kan substituenterna på fenylgrup- pen väljas från ett stort antal grupper och valet begränsas 5 t endast av den fenylalanin, som är den önskade slutproduké ten. Dessutom kan det-förekomma att sådana substituentgrup- per.själva är förelöpare till substituenter, som önskas i slutprodukten och lätt kan omvandlas till sådana önskade substituenter. Om exempelvis den substituerade bensaldehy- 10 den.ër vanillin och man önskar framställa 5-(5,4-dihydroxi- fenyl)-alanin, kan den omättade förelöparen vara.x-acet- amido-4-hydroxi~5~metoxi-kanelsyra, som skulle ge N-acetyl- 5-(4-hvdroxi-5-metoxiíenyl)-alanin genom hydreríng. Denna kan därefter omvandlas till 5-(5,4-díhydroxífenyl)-alanin 15 genom enkel hydrolys.i v i L-enantíomeren av sådana fenylalaniner är speciellt önskvärda. Sålunda är exempelvis 5-(5,4-dihydroxifenyl)-L- alanin (L-DOPA) välkänd för sin användbarhet för behand- ling av symptomen vid Parkinsons sjukdom. Likaledes har 20 L-fenylalanin visat sig användbar som mellanprodukt för framställning av alkylestrarna av L-aspartyl~L-fenylala- nin, som nyligen visat sig vara utmärkta syntetiska söt- medel.~ 10 15 20 25 30 35 40 5 7900355 *4 De optiskt aktiva hydreringskatalysatorerna, som är an- 'vändbara vid sättet enligt uppfinningen, är i reaktionsmassan lösliga koordinationskomplex innehållande en metall ur gruppen rodium, iridium, rutenium, osmium, palladium och platina i kombination med minst en katalytiskt aktiv fosfin- eller arsin- ligand. Dessa katalysatorer är lösliga i reaktionsmassan och betecknas därför som homogena katalysatorer.An especially preferred embodiment, which is also illustrative of hydrogenation with the catalyst according to the invention, is the preparation of the substituted and unsubstituted phenylalanines by catalytic asymmetric hydrogenation. Unsaturated precursors for such Obamino acids can be prepared according to Erlenmeyer's azlactone synthesis, wherein a substituted or unsubstituted benzaldehyde is reacted with an acylglycine, for example acetylglycine, and acetic anhydride to azlactone, which is hydrolyzed to the unsaturated precursor pair. Such a reaction is illustrated by the following reaction scheme, in which benzaldehyde and acetylglycine are used as examples of reactants: vanessa-n i - ioio ll - Il. '' '(1) Q-CHO + CH5C-1 \ 1H- CH2COOH- + O (C-CH3) 2 -) <\: /> - CH = (, JT_ (|) = O _ 'à V: cH 5 (2) Quinn-om .____.___ + h3'dI In such reactions, the substituents on the phenyl group can be selected from a large number of groups and the choice is limited only by the phenyl group. phenylalanine, which is the desired end product. In addition, such substituent groups themselves may be precursors to substituents desired in the final product and can be readily converted to such desired substituents. For example, the substituted benzaldehyde is vanillin. and it is desired to produce 5- (5,4-dihydroxyphenyl) -alanine, the unsaturated precursor may be α-acetamido-4-hydroxy-5-methoxy-cinnamic acid, which would give N-acetyl-5- ( 4-Hydroxy-5-methoxyphenyl) -alanine by hydrogenation. Converted to 5- (5,4-dihydroxyphenyl) -alanine by simple hydrolysis in the L-enantiomer of such phenylalanines are particularly desirable. Thus, for example, 5- (5,4-dihydroxyphenyl) -L-alanine (L-DOPA) is well known for its utility in treating the symptoms of Parkinson's disease. Likewise, 20-L-phenylalanine has been found to be useful as an intermediate for the preparation of the alkyl esters of L-aspartyl-L-phenylalanine, which have recently been shown to be excellent synthetic sweeteners. The optically active hydrogenation catalysts useful in the process of the invention are soluble coordination complexes containing a metal of the group rhodium, iridium, ruthenium, osmium, palladium and platinum in combination with at least one catalytically active phosphine or arsine ligand. These catalysts are soluble in the reaction mass and are therefore referred to as homogeneous catalysts.
Fosfin- eller arsinliganden kan exempelvis ha formeln ARSRÖIÜ, RS, RÖ och R7 den ena oberoende av den andra representerar en väteatomš en alkyl- eller alkoxigrupp med 1-12 kolatomer; en substi- där A är fosfor eller arsenik och var och en av symbolerna tuerad alkylgrupp, i vilken'substituenterna är valda bland följande, nämligen amino, karbonyl, aryl, nitro och_alkoxi, vilken alkoxi innehåller högst 4 kolatomer; en arylgrupp; en aryloxigrupp; en fenylgrupp; en med mindre än 3 substituenter substituerad fenyl-_ grupp, varvid substituenterna är valda bland följande, nämligen alkoxi och alkyl, hydroxi, aryloxi, amino och nitro; cykloalkyl med minst 3 kolatomer; substituerad cykloalkyl; pyrryl; tienyl; furyl; pyridyl; piperidyl; och 3-kolesteryl.The phosphine or arsine ligands may, for example, have the formula ARSRÖIÜ, RS, RÖ and R7, one independently representing a hydrogen atom or an alkyl or alkoxy group having 1-12 carbon atoms; a substituent A is phosphorus or arsenic and each of the symbols is an alkyl group, in which the substituents are selected from the following, namely amino, carbonyl, aryl, nitro and alkoxy, which alkoxy contains at most 4 carbon atoms; an aryl group; an aryloxy group; a phenyl group; a phenyl group substituted with less than 3 substituents, the substituents being selected from the following, namely alkoxy and alkyl, hydroxy, aryloxy, amino and nitro; cycloalkyl having at least 3 carbon atoms; substituted cycloalkyl; pyrryl; thienyl; furyl; pyridyl; piperidyl; and 3-cholesteryl.
Optisk aktivitet hos metallkoordinationskomplexen enligt uppfinningen ligger hos fosfin- eller arsinliganden. Denna optiska' aktivitet kan bero antingen på att det på fosfor- eller arsenik- atomen sitter tre olika grupper eller på att en optiskt aktiv grupp är bunden vid fosfor- eller arsenikatomen.Optical activity of the metal coordination complexes of the invention lies in the phosphine or arsine ligand. This optical activity may be due either to the presence of three different groups on the phosphorus or arsenic atom or to the fact that an optically active group is attached to the phosphorus or arsenic atom.
Som belysande exempel på koordinationsmetallkomplex kan nämnas sådana med formeln M¥XnL3 eller M2X2L2, där M1 är en av metallerna rodium, iridium, rutenium ellerïosmiumg M2 är palladium eller platina; X är väte, fluor, brom, klor eller jod; L, såsom ovan angivits, är fosfinl eller arsinliganden; och n är ett helt _ tal l eller 3.As illustrative examples of coordination metal complexes may be mentioned those of the formula M ¥ XnL3 or M2X2L2, where M1 is one of the metals rhodium, iridium, ruthenium or iososium and M2 is palladium or platinum; X is hydrogen, fluorine, bromine, chlorine or iodine; L, as indicated above, is phosphinyl or the arsine ligand; and n is an integer 1 or 3.
-I de ovan angivna formlerna för koordinationsmetallkomplex behöver endast en ligand (L) vara optiskt aktiv för att sättet enligt uppfinningen skall fungera.In the above formulas for coordination metal complexes, only one ligand (L) needs to be optically active for the method of the invention to work.
Om ligandens optiska aktivitet består i att en optiskt aktiv grupp är bunden vid fosfor- eller arsenikatomen, behöver det endast finnas en sådan grupp och de två andra grupperna kan vara lika eller inaktiva. I detta fall behöver endast en av grupperna Rå, RÖ eller R7 vara optiskt aktiv och de återstående två grupperna kan vara identiska eller inaktiva. 10 15 25 6 Användbara katalysatorer faller under följande formler för koordinationsmetallkomplex men är icke begränsade till' dessa. I formlerna anger en asterisk asymmetri och därmed optisk aktivitet. Asterisken betecknar den asymmetriska ato- men eller den dissymmetriska gruppen. Som exempel antyder A* ) i att fosfor- eller arsenikatomen är asymmetrisk. Ingen asterisk innebär "ingen optisk aktivitet".If the optical activity of the ligand is that an optically active group is attached to the phosphorus or arsenic atom, there need be only one such group and the other two groups may be the same or inactive. In this case, only one of the groups Ra, RÖ or R7 need be optically active and the remaining two groups may be identical or inactive. Useful catalysts fall under the following formulas for coordination metal complexes but are not limited thereto. The formulas indicate an asterisk asymmetry and thus optical activity. Asterisk denotes the asymmetric atom or the dissymmetric group. By way of example, A *) indicates that the phosphorus or arsenic atom is asymmetric. No asterisk means "no optical activity".
MlX(A*>R5R6R7)5 M1x(A*)R5R6R7)2(AR5R6R7) M1X(A*)R5R6R7) (AR5R6R7)2 M1X(AR*)5R6R7)5 Mix(AR*)5R6R7) (AR5R6R7)2 M1x5(A*)R5R6R7)5 Mlxš(A*)R5R6R7)2(AR5R6R7) WM1X3(A*)R5R6R7) (AR5R6R7)2 M1x(AR*)5R6R7)2(AR5R6R7) M1X3(AR*)5R6R7)5 M1x5(AR*)5R6R7)2(AR5n6R7) M2x¿(A*ÜR5R6R7) (AR5R6R7) s ~M1X5(AR*)5R5R7) (AR5R6R7)2 _M2X2(AR*)5R6R7)2 M2X2(A*)R5R6R7)2 M2X2(AR*)5R6R7) (AR5R6R7) RnX(A¿R5R6R7)5 RhX5(A*k5R6R7)3 Rhx5(A*R5R6R7)2(AR5R5R7) -Rhx5(A*R5R6R7)(AR5R6R7)2 RnX5(AR*5R5R7)5 RhX3(AR*5R6R7)2(AR5R5R7) Rhx(A*R5R6R7)2(AB5R6R7) RnX(A°'R5R6R7) (A125126R7) 2 Rhx(AR*5R5R7)5 _ RhX(AR*5R6R7)2(AR5R6R7) RnX(AR*5R5R7)(AR5R5R7)2 RhX5(AR*5R6R7)(AR5R6R7)2 där M1, M2, X, A, R5, R6.och R? har ovan angivna betydelser. _I den ovan som exempel angivna listan av katalysatorer kan den dissymmetriska gruppen vara R5, R6 eller R? och är icke begränsad till någon enstaka grupp. Dessutom kan.det förekomma en kombination av grupper bundna vid metallen. 7900355-A 7 lO 15 20 Givetvis representerar de ovan angivna formlerna icke endast de koordinationsmetallkomplex, som innehåller två eller tre ligander, såsom i formlerna LÉXZLZ respektive MIXHL3, utan också de koordinationsmetallkomplex, i vilka antalet ligand-metall- koordinationsbindningar'beskrives med antalet L i formeln och i ' vilka dessa bindningar tillhandahålles av flertandade ligander.M1X (A *> R5R6R7) 5 M1x (A *) R5R6R7) 2 (AR5R6R7) M1X (A *) R5R6R7) (AR5R6R7) 2 M1X (AR *) 5R6R7) 5 Mix (AR *) 5R6R7) (AR5R6R7) 2 M1 (A *) R5R6R7) 5 Mlxš (A *) R5R6R7) 2 (AR5R6R7) WM1X3 (A *) R5R6R7) (AR5R6R7) 2 M1x (AR *) 5R6R7) 2 (AR5R6R7) M1X3 (AR *) 5R6x7 AR *) 5R6R7) 2 (AR5n6R7) M2x¿ (A * ÜR5R6R7) (AR5R6R7) s ~ M1X5 (AR *) 5R5R7) (AR5R6R7) 2 _M2X2 (AR *) 5R6R7) 2 M2X2 (A *) R5R2R2) AR *) 5R6R7) (AR5R6R7) RnX (A¿R5R6R7) 5 RhX5 (A * k5R6R7) 3 Rhx5 (A * R5R6R7) 2 (AR5R5R7) -Rhx5 (A * R5R6R7) (AR5R6R7) 2 RnXR (AR * RhX3 (AR * 5R6R7) 2 (AR5R5R7) Rhx (A * R5R6R7) 2 (AB5R6R7) RnX (A ° 'R5R6R7) (A125126R7) 2 Rhx (AR * 5R5R7) 5 _ RhX (AR * 5R6R7) 2 (AR5RXR7 (AR * 5R5R7) (AR5R5R7) 2 RhX5 (AR * 5R6R7) (AR5R6R7) 2 where M1, M2, X, A, R5, R6 and R6? has the meanings given above. In the above list of catalysts exemplified, the dissymmetric group may be R5, R6 or R6? and is not limited to any single group. In addition, there may be a combination of groups attached to the metal. Of course, the above formulas represent not only the coordination metal complexes containing two or three ligands, as in formulas LÉXZLZ and MIXHL3, respectively, but also the coordination metal complexes in which the number of ligand-metal coordination bonds is described by the number L in the formula and in which these bonds are provided by multi-toothed ligands.
Ehuru det sålunda exempelvis kan förekomma endast två ligander i efi;visstkoordinationsmetallkomplex representerar formeln MIXHL3 fortfarande komplexen, om en av de båda liganderna är tvåtandad, dvs. ger två koordinationsbindningar. Likaledes representerar formeln MlXnL3 också de komplex, i vilka det endast_ingår en _ ligand, nämligen om denna är tretandad, dvs. ger tre koordinations- bindningar. gßland substituenterna på fosfor- och arsenikatomerna ka nämnas metyl, etyl, propyl, isopropyl,-butyl, pentyl, hexyl, heptyl, oktyl, nonyl, dekyl, undekyl, dodekyl, cyklopropyl, cyklobutyl, cyklopentyl, cyklohexyl, fenyl, acetoxifenyl, metylfenyl, etyl- fenyl, propylfenyl, butylfenyl, dimetylfenyl, trimetylfenyl, dietylfenyl, hydroxifenyl, fenoxifenyl, o-anisyl, 3-kolesteryl, bensyl, pyrryl, furyl, pyridyl, tienyl, píperidyl, mentyl, bornyl och pinyl. Bland de ovannämnda substituenterna fr.o.m. butyl t.o.m. 10 15 20 25 30 35 40- 8 t veoosss-u dodecyl innefattas givetvis isomerer därav. Substituenterna är emellertid icke begränsade till de ovan uppräknade.Thus, for example, although there may be only two ligands in a certain coordination metal complex, the formula MIXHL3 still represents the complexes, if one of the two ligands is bidentate, ie. provides two coordination bonds. Likewise, the formula MlXnL3 also represents the complexes in which there is only one ligand, namely if it is three-toothed, i.e. provides three coordination bonds. The substituents on the phosphorus and arsenic atoms may be methyl, ethyl, propyl, isopropyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, acetoxyphenyl, methyl ethylphenyl, propylphenyl, butylphenyl, dimethylphenyl, trimethylphenyl, diethylphenyl, hydroxyphenyl, phenoxyphenyl, o-anisyl, 3-cholesteryl, benzyl, pyrryl, furyl, pyridyl, thienyl, piperidyl, mentyl, bornyl and pinyl. Among the above-mentioned substituents fr.o.m. butyl t.o.m. Of course, isomers thereof are included. However, the substituents are not limited to those listed above.
För ändamålet enligt uppfinningen kan följande optiskt aktiva fosfiner och arsiner användas, men uppfinningen är givetvis icke begränsad till dessa: metyletylfosfin, metylisopropylfosfin, étylbutylfosfin, isopropylisobutylfosfin, metylfenyjfosfin, etyl-' fenylfosfin, propylfenylfosfin, butylfenylfosfin, fenylbensyl- fosfin, fenylpyrrolfosfin, etylisopropylisobutylfosfin, metylfenyl- 4-metylfenylfosfin, etylfenyl-4-metylfenylfosfin, metylisopropyl- fenylfosfin.etylfenyl-2,4,5-trimetylfenylfosfin, fenylbensyl-4- gdimetylaminofenylfosfin, fenylpyridylmetylfosfin, fenylcyklopentyl- etylfosfin, cyklohexylmetylisopropylfosfin, o-metoxifenylmetyl- fenylfosfin,_o-metoxifenylcyklohexylmetylfosfin och de motsvarande arsenikanalogerna. I _ För ändamålet enligt uppfinningen föredrages i synnerhet de optiskt aktiva fosfiner och arsiner, som innehåller minst en .fenylgrupp,fvilken uppbär en substituent i orto-ställningen, exem- pelvis hydroxi; alkoxi med l-l2 kolatomer; och aryloxi.'Utmärkta resultat har erhållits med metylfenyl-o-anisylfosfin och metyl- oyklohexyl-o-anisylfosfin, Den sistnämnda föreningen och de därmed framställda optiskt aktiva koordinationsmetallkomplex-hydrerings- katalysatorerna är nya och det har visat sig, att de önskade enantiomererna av substituerade och osubstituerade fenylalaníner lätt framställes i utmärkta utbyten, när man använder_sådana optiskt aktiva ligander i sättet enligt uppfinningen.For the purpose of the invention, the following optically active phosphines and arsines may be used, but the invention is of course not limited thereto: methylethylphosphine, methylisopropylphosphine, ethylbutylphosphine, isopropylisobutylphosphine, methylphenylphosphine, ethylphenylphosphine, propylphenylphenylphenylphenylphenylphenylphenylphosphyl, - 4-methylphenylphosphine, ethylphenyl-4-methylphenylphosphine, metylisopropyl- fenylfosfin.etylfenyl-2,4,5-trimetylfenylfosfin, phenylbenzyl-4- gdimetylaminofenylfosfin, fenylpyridylmetylfosfin, fenylcyklopentyl- etylfosfin, cyklohexylmetylisopropylfosfin, o-methoxyphenylmethyl phenylphosphine, _o-metoxifenylcyklohexylmetylfosfin and corresponding to the arsenic analogues. For the purpose of the invention, particularly preferred are the optically active phosphines and arsines which contain at least one phenyl group which carries a substituent in the ortho position, for example hydroxy; alkoxy having 1-2 carbon atoms; and aryloxy. Excellent results have been obtained with methylphenyl-o-anisylphosphine and methyl-oclohexyl-o-anisylphosphine. The latter compound and the optically active coordination metal complex hydrogenation catalysts thus prepared are novel and it has been found that the desired Substituted and unsubstituted phenylalanines are readily prepared in excellent yields when using such optically active ligands in the method of the invention.
Ehuru endast en optiskt aktiv grupp eller ligand erfordras i koordinationsmetallkomplekkatalysatorn föredrages för underlättan- de av framställningen att alla tre liganderna i den ovan beskrivna formeln M1XnL3 är inbördes lika. Qet föredrages också att asymme- trin ligger hos fosfor- eller arsenikatomen. ' V Det har visat sig, att utmärkta utbyten av de önskade enantiomererna kan erhållas icke endast med de ovan beskrivna óptiskt aktiva hydreringskatalysatorerna, som är koordinations-' metallkomplex av en av metallerna rodium, iridium, rutenium, osmium, palladium och platina, utan man kan även erhålla goda utbyten, när hydreringen genomföres i närvaro av en katalysator, som består av 7 en lösning av metallerna rodium, iridium, rutenium, osmium, palla- dium och platina och minst en ekvivalent av en fosfin- och/eller arsinligand per mol metall, förutsatt att liganden är optiskt aktiv.Although only one optically active group or ligand is required in the coordination metal complex catalyst, it is preferred for ease of preparation that all three ligands in the formula M1XnL3 described above be equal. It is also preferred that the asymmetry be located at the phosphorus or arsenic atom. It has been found that excellent yields of the desired enantiomers can be obtained not only with the optically active hydrogenation catalysts described above, which are coordination metal complexes of one of the metals rhodium, iridium, ruthenium, osmium, palladium and platinum, but without can also obtain good yields when the hydrogenation is carried out in the presence of a catalyst consisting of a solution of the metals rhodium, iridium, ruthenium, osmium, palladium and platinum and at least one equivalent of one phosphine and / or arsine ligand per mole metal, provided that the ligand is optically active.
Som exempel kan nämnas, att katalysatorn kan framställas genom 7900355-4, 10 15 20 25 35 40 9 upplösning av en löslig metallförening i ett lämpligt lösningsmedel tillsammans med en ligand, varvid förhållandet ligand:metall är minst en ekvivalent ligand per mol metall, företrädesvis två ekvi- valenter ligand per mol metall. Likaledes har det visat sig, att katalysatorn kan framställas in situ genom tillsats av en löslig metallförening till reaktionsmassan tillsammans med en tillsats av den lämpliga mängden av den optiskt aktiva liganden till reaktions- massan antingen före eller under hydreringen.By way of example, the catalyst may be prepared by dissolving a soluble metal compound in a suitable solvent together with a ligand, the ligand: metal ratio being at least one equivalent of ligand per mole of metal, preferably two equivalents of ligand per mole of metal. Likewise, it has been found that the catalyst can be prepared in situ by adding a soluble metal compound to the reaction mass together with an addition of the appropriate amount of the optically active ligand to the reaction mass either before or during the hydrogenation.
Rodium föredrages som metall. Bland användbara, lösliga rodiumföreningar kan nämnas rodiumtriklorhydrat, rodiumtribromid- hydrat, rodiumsulfat, organiska rodiumkomplex med eten, propen etc. och bisolefiner, såsom 1,5-cyklooktadien och l,5~hexadien, bicyklo-' 2.2.1-hepta-2,5-dien och andra diener, som kan bilda tvåtandade ligander, eller en aktiv.form av metalliskt rodium, som är lätt- solubiliserad.Rhodium is preferred as the metal. Useful soluble rhodium compounds include rhodium trichlorohydrate, rhodium tribromide hydrate, rhodium sulfate, organic rhodium complexes with ethylene, propylene, etc. and bisolefins, such as 1,5-cyclooctadiene and 1,5-hexadiene, bicyclo-2,2,1-hepta-2, 5-diene and other dienes, which may form bidentate ligands, or an active form of metallic rhodium, which is readily solubilized.
Det har visat sig, att sättet enligt uppfinningen före-' trädesvis genomföras i närvaro av en optiskt aktiv fosfin- eller arsinligand, varvid liganden föreligger i ett förhållande av ca 1,5 till ca 2,5 (företrädesvis 2,0) ekvivalenter ligand per mol metall. I praktiken föredrages för handhavande och lagring att använda den optiskt aktiva katalysatorn i fast form. Det har visat sig, att dessa resultat kan uppnås med fasta, katjoniska koordina- tionsmetallkomplex. u' Katjoniska koordinationsmetallkomplex innehållande två ekvivalenter fosfin eller arsin per mol metall och en kelatbil- dande bis-olefin kan användas som katalysatorer för ändamålet enligt uppfinningen. Sålunda kan man vid användning av de ovan beskrivna organiska rodiumkomplexen framställa sådana katjoniska koordinationsrodiumkomplex genom uppslamning av det organiska rodiumkomplexet i en alkohol, exempelvis etanol, tillsätta två Å ekvivalenter av den optiskt aktiva fosfinen eller arsinen, så att 'det bildas en jonlösning, varpå en lämplig anjon tillsättes, exempelvis tetrafluorborat, tetrafenylborat eller vilken som helst annan anjon, som fäller eller utkristalliserar ett_fa3t,kafij0nigkt koordinationsmetallkomplex antingen direkt ur lösningen eller vid behandling i ett lämpligt lösningsmedel. ' Som exempel på katjoniska koordinationsmetallkomplex kan nämnas cyklooktadien-1,5-bis(metylcyklohexyl-o-anisylfosfin2- rodiumtetrafluorborat, cyklooktadien-1,5-bis(metylcyklohexyl-o- anisylfosfin)-rodiumtetrafenylborat och bicyk1o-2,2.l-hepta-2,5- 10 15 20 25 30 35 40 a79oozss-A 40 dienëbis(metylcyklohexyl-o-anisylfosfin)-rodiumtetrafluorboratw Utan att binda uppfinningen vid någon speciell teori an: tages att katalysatorn föreligger i form av ett förstadium, som vid kontakt med väte omvandlas till aktiv form. Denna omvandling kan givetvis genomföras under själva hydreringen av olèfinbind- ningen eller också kan katalysatorn eller förstadiet därav hydre- ras före tillsatsen till olefinmaterialet, som skall hydreras.It has been found that the method of the invention is preferably carried out in the presence of an optically active phosphine or arsenic ligand, the ligand being present in a ratio of about 1.5 to about 2.5 (preferably 2.0) equivalents of ligand per mol metal. In practice, for handling and storage, it is preferred to use the optically active catalyst in solid form. It has been found that these results can be achieved with solid, cationic coordination metal complexes. Cationic coordination metal complexes containing two equivalents of phosphine or arsine per mole of metal and a chelating bis-olefin can be used as catalysts for the purpose of the invention. Thus, using the organic rhodium complexes described above, such cationic coordination rhodium complexes can be prepared by suspending the organic rhodium complex in an alcohol, for example ethanol, adding two equivalents of the optically active phosphine or arsine to form an ionic solution, whereupon a Suitable anion is added, for example tetrafluoroborate, tetraphenylborate or any other anion which precipitates or crystallizes a solid co-ordinating coordination metal complex either directly from the solution or by treatment in a suitable solvent. Examples of cationic coordination metal complexes which may be mentioned are cyclooctadiene-1,5-bis (methylcyclohexyl-o-anisylphosphine-2-rhodium tetrafluoroborate, cyclooctadiene-1,5-bis (methylcyclohexyl-o-anisylphosphine) -rodium tetraphenylborate and 2,icyclic -2,5- 10 15 20 25 30 35 40 a79oozss-A 40 dienebis (methylcyclohexyl-o-anisylphosphine) -rodium tetrafluoroboratate Without binding the invention to any particular theory, it is believed that the catalyst is in the form of a precursor which upon contact with This conversion can of course be carried out during the actual hydrogenation of the olefin bond or the catalyst or its precursor can be hydrogenated before the addition to the olefin material to be hydrogenated.
' Hydreringen genomföres vanligtvis i ett sådant lösnings- medel som bensen, etanol, toluen, cyklohexan eller en blandning av två eller flera av dessa. Nästan vilken som helst aromat, mättad alkan eller cykloalkan, som är inaktiv gentemot hydreringsbetingel- serna vid sättet enligt uppfinningen kan användas som lösningsmedel Enär bydreringen enligt uppfinningen har visat sig vara specifik kan även sådana lösningsmedel som nitrobensen användas. Som lös- ningsmedel föredrages emellertidnænanol.The hydrogenation is usually carried out in a solvent such as benzene, ethanol, toluene, cyclohexane or a mixture of two or more of these. Almost any aromatic, saturated alkane or cycloalkane which is inert to the hydrogenation conditions in the process of the invention can be used as a solvent. Since the by-preparation according to the invention has been found to be specific, such solvents as nitrobenzene can also be used. However, nanolanol is preferred as the solvent.
Såxm ovan.angivits sättes katalysatorn till lösningsmedlet antingen i form av en förening som sådan eller i form av förening- ens komponenter, som i så fall bildar katalysatorn in situ. När katalysatorn tillsättes i form av-sina komponenter kan dessa till- sättas före eller samtidigt med denlåïsubstituerade O6-acylamino- akrylsyran. Komponenter för framställning av katalysatorn in situ V är den lösliga metallföreningen och den optiskt aktiva fosfin- eller arsinliganden.As indicated above, the catalyst is added to the solvent either in the form of a compound as such or in the form of the components of the compound, which in that case form the catalyst in situ. When the catalyst is added in the form of its components, these may be added before or simultaneously with the loosely substituted O6 acylaminoacrylic acid. Components for the preparation of the catalyst in situ V are the soluble metal compound and the optically active phosphine or arsine ligand.
.Katalysatorn kan tillsättas i vilken som helst effektiv katalytisk mängd, vanligtvis i en mängd mellan ca 0,000l och ca I 5 viktprocent av i katalysatorn ingående metall räknat på mängden ßLsubstituerad e< -acylaminåakrylsyra och/eller salt därav. 7 Åtgärder bör inom praktiska gränser vidtagas för undvikan- de av kontakt mellan katalysatorn eller reaktionsmassan och oxide- rande material. I synnerhet bör man vidtaga försiktighetsåtgärder "för undvikande av kontakt med syre; Det föredrages att preparera hydreringsreaktionen och genomföra själva hydreringen i gaser (andra än H2) som är inerta gentemot båda reaktionskomponenterna och katalysatorerna, exempelvis kväve eller koldioxid. rSåsom ovan påpekats har det nu visat sig, att den asymmet- riska hydreringen ökas genom närvaron-av en bas i reakmionsmassan.The catalyst may be added in any effective catalytic amount, usually in an amount between about 0.000l and about 5% by weight of metal contained in the catalyst based on the amount of β-substituted ε-acylaminoacrylic acid and / or salt thereof. 7 Measures should be taken within practical limits to avoid contact between the catalyst or the reaction mass and the oxidizing material. In particular, precautions should be taken "to avoid contact with oxygen; it is preferred to prepare the hydrogenation reaction and to carry out the actual hydrogenation in gases (other than H 2) which are inert to both reactants and catalysts, for example nitrogen or carbon dioxide. It has been found that the asymmetric hydrogenation is increased by the presence of a base in the reaction mass.
Ehuru den asymmetriska hydreringen kan genomföras i en reaktions- massa, som är fri från bas och t.o.m. i en sur reaktionsmassa, “förbättras utbytet, om man till reaktionsmassan sätter små mängder o av ett basiskt material, nämligen upp till högst en ekvivalent per l všoosss-4 10 15 20 25 V30 _ 35 40 11 mol akrylsyra. Det är förvånande, att en ringa mängd bas, som sättes till en t.o.m. sur reaktionsmassa ger förbättrad asymmet- 'risk hydrering och det har visat sig, att bildningen av en ringa' mängd salt av akrylsyra är tillräcklig för erhållande av förbättra- de resultat.Although the asymmetric hydrogenation can be carried out in a reaction mass which is free from base and up to in an acidic reaction mass, the yield is improved if small amounts of a basic material are added to the reaction mass, namely up to a maximum of one equivalent per liter of acrylic acid. It is surprising that a small amount of base, which is added to a t.o.m. acidic reaction mass gives improved asymmetric hydrogenation and it has been found that the formation of a small amount of salt of acrylic acid is sufficient to obtain improved results.
Bland användbara baser kan nämnas tertiära baser, såsom trietylamin, vidare Na0H och nästan vilket som helst annat basiskt material, som bildar ett salt med karboxylsyror.Useful bases include tertiary bases, such as triethylamine, further NaOH and almost any other basic material which forms a salt with carboxylic acids.
Efter tillsats av komponenterna till lösningsmedlet till- föres väte till blandningen, till dess att man tillfört mellan ca l och ca 5 gånger molmängdenjlsubstitueradoßacylaminb-akrylsyra eller en mängd, som erfordras för fullständig hydrering till den önskade nivån. Trycket i systemet varierar med nödvändighet, enär det beror på typen fl-substituerad oc-acylamino-alcrylsyra, kataly- satortypen, hydreringsapparatens dimensioner, mängden komponenter och mängden lösningsmedel och/eller bas. Lägre tryck, inklusive atmosfärstrycket och underatmosfäriskt tryck kan tillämpas liksom även högre tryck.After adding the components to the solvent, hydrogen is added to the mixture, until between about 1 and about 5 times the molar amount of substituted adacacamine amacrylic acid or an amount required for complete hydrogenation to the desired level is added. The pressure in the system necessarily varies, since it depends on the type fl-substituted α-acylamino-acrylic acid, the type of catalyst, the dimensions of the hydrator, the amount of components and the amount of solvent and / or base. Lower pressures, including atmospheric pressure and subatmospheric pressure can be applied as well as higher pressures.
Reaktionstemperaturen kan ligga mellan ca -20 och ca l10°C.The reaction temperature can be between about -20 and about 110 ° C.
Högre temperaturer kan tillämpas men erfordras normalt icke och kan leda till att bireaktioner accelereras.Higher temperatures can be applied but are not normally required and can lead to accelerated side reactions.
När reaktionen slutförts, vilket fastställes på konven- 'tionellt sätt, avlägsnas lösningsmedlet och produkterna och kata- lysatorn avskiljes med vanliga medel.When the reaction is complete, which is determined in a conventional manner, the solvent is removed and the products and the catalyst are separated by ordinary means.
Många i naturen förekommande produkter och mediciner före- kommer i en optiskt aktiv form. I detta fall är vanligtvis endast L- eller D-formen effektiv. Syntetisk framställning av dessa före- ningar har hittills erfordrat ytterligare steg, nämligen separation av produkterna i deras enantiomerer. Detta är tidskrävande och I dyrbart. Sättet enligt uppfinningen möjliggör framställning av optiskt aktiva produkter, varigenom nämnda tidskrävande och dyrbara separation elimineras samtidigt som utbytena av de önskade enantio- mererna ökas och mängden icke önskad enantiomer minskas. önskade enantiomerer avs!-aminosyror kan framställas genom hydrering av den lämpligtlß-substituerade oC-acylamifloakryl- syran på sätt som avses enligt förevarande uppfinning ätföljd av avlägsnandet av acylgruppen påa<-aminogruppen och de andra skyddan- de grupperna på konventionellt sätt, så att man erhåller den önska- de enantiomeren. ' Det har nu visat sig, atta<-aminosyror framställda av de U! 10 15 20 25 30 35 40 i' ' de veoosss-4 42 jgésubstituerade 04-acylamidoakrylsyrorna och/eller salter därav) lätt kan framst"llas med stor övervikt av den önskade enantiomeren, viikef gör att förevaàanae uppfinning b1i: speciellt värdefull.Many naturally occurring products and medicines occur in an optically active form. In this case, usually only the L- or D-shape is effective. Synthetic preparation of these compounds has so far required further steps, namely separation of the products into their enantiomers. This is time consuming and expensive. The method according to the invention enables the production of optically active products, whereby said time-consuming and expensive separation is eliminated at the same time as the yields of the desired enantiomers are increased and the amount of undesired enantiomer is reduced. desired enantiomers of β-amino acids can be prepared by hydrogenating the suitably β-acylaminoacrylic acid in the manner of the present invention followed by the removal of the acyl group on the α-amino group and the other protecting groups in a conventional manner so as to receives the desired enantiomer. 'It has now been shown, atta <-amino acids produced by the U! The α 4 -acylamidoacrylic acids and / or salts thereof can be readily prepared with a large predominance of the desired enantiomer, which makes the present invention particularly valuable.
I följande exempel visas i närmare detalj hur sättet enligt uppfinningen genomföres. Givetvis är emellertid uppfinningen icke begränsad till dessa detaljer. Med "delar" avses viktdelar, därest annat icke uttryckligen angives. I exemplen har % optisk renhet bestämts med följande ekvation (de optiska aktiviteterna är givetvis uttryckta som de specifika vridningarna, vilka bestämts i'ett och samma lösningsmedel): % optisk observerad optisk aktivitet för blandningen X lO( renhet optisk aktivitet av den rena enantiomeren Exempel 1: De optiskt aktiva fosfínerna och arsinerna kan fram- ställas på det sätt, som beskrives av Mislow och Korpiun, J. Am.The following examples show in more detail how the method according to the invention is carried out. Of course, however, the invention is not limited to these details. "Parts" means parts by weight, unless otherwise expressly stated. In the examples,% optical purity has been determined by the following equation (the optical activities are of course expressed as the specific rotations, which are determined in one and the same solvent):% optically observed optical activity for the mixture X 10 (purity optical activity of the pure enantiomer Example 1: The optically active phosphines and arsines can be prepared in the manner described by Mislow and Korpiun, J. Am.
Chem. soc” 89, 4784 (1967). ' -----+ 1- PhPC12 + 2 CH30H en P(0cH3)2 _ Ett lämpligt kärl utrustat med omrörare, temperaturmät- níngsanordning och beskkktningsanordning beskkkades med 250 delar fenyldiklorfosfin, 240 delar pyridin och 495 delar hexan. Lösningen ïkyldes till ungefär 5-lO°C och en blandning bestående av 96 delar metanol och 27 delar hexan tillsattes under omrörning under loppet av ca 1,5 timmar. Den så erhållna blandningen omrördes under ytter- ligare 2,5 timmar medan den uppvärmdes till ungefär 25°C. Reak- tionen genomfördes i inert kväveatmosfär.Chem. soc ”89, 4784 (1967). ----- + 1- PhPC12 + 2 CH3OH a P (0cH3) 2 A suitable vessel equipped with a stirrer, temperature measuring device and coating device was coated with 250 parts of phenyldichlorophosphine, 240 parts of pyridine and 495 parts of hexane. The solution was cooled to about 5-10 ° C and a mixture consisting of 96 parts of methanol and 27 parts of hexane was added with stirring over about 1.5 hours. The mixture thus obtained was stirred for a further 2.5 hours while heating to about 25 ° C. The reaction was carried out in an inert nitrogen atmosphere.
I Pyridínhydroklorid, somfbildades under reaktionen, av- filtrerades och filtratet koncentrerades. Den gula återstoden destillerades, man uppsamlade en färglös fraktion med destillations- intervall 95,5-97°c/17 mm Hg (s2% utbyte av dimetylfenylfosfonif).The pyridine hydrochloride formed during the reaction was filtered off and the filtrate was concentrated. The yellow residue was distilled, collecting a colorless fraction with a distillation range of 95.5-97 ° c / 17 mm Hg (s2% yield of dimethylphenylphosphonif).
(Harwooa and Gxisley J. Am. chem. soc., az, 423 (1960)) _ g v. _ _ O PhP(ocH3)2 + cH3I_ -----> Ph?-ocns CH3 _ Ett lämpligt kärl utrustat med omrörare,_temperaturmät- ningsanordning och beskflflflmingsanordning beskkkades med ll delar dimetylfenylfosfonit, 2;5 delar metyljodid och 9 delar toluen.(Harwooa and Gxisley J. Am. Chem. Soc., Az, 423 (1960)) _ g v. _ _ O PhP (ocH3) 2 + cH3I_ -----> Ph? -Ocns CH3 _ A suitable vessel equipped with stirrer, temperature measuring device and protection device was charged with 11 parts of dimethylphenylphosphonite, 2; 5 parts of methyl iodide and 9 parts of toluene.
* Den så erhållna lösningen upphettades långsamt. Reaktionen var exotermisk.och temperaturen steg till ca ll0°C. Reaktionsblandninger 79~0035f5 '14 10 15 20 25 30* 40 45 hölls vid en temperatur av ungefär 100-l20°C och ytterligare l85 delar dimetylfenylfosfonit tillsattes långsamt. Ytterligare mängder metyljodid i portioner om ungefär l del vardera tillsattes tid efter annan under fosfoníttillsatsen. Reaktionsblandningen hölls vid ungefär l10°C under ytterligare l timme, sedan komponen- terna tillsatte. Reaktionsblandningen destillerades därefter och _ man uppsamlade en portion med destillationsintervall l48~l49°C/17 mm Hg (96% utbyte av metylfenylmetylfosfinat).* The solution thus obtained was slowly heated. The reaction was exothermic and the temperature rose to about 110 ° C. Reaction mixtures were maintained at a temperature of about 100 DEG-120 DEG C. and a further 185 parts of dimethylphenylphosphonite were added slowly. Additional amounts of methyl iodide in portions of about 1 part each were added time after time during the phosphonite addition. The reaction mixture was kept at about 110 DEG C. for a further 1 hour after the components were added. The reaction mixture was then distilled and a portion was collected with a distillation range of 148 DEG-149 DEG C./17 mm Hg (96% yield of methylphenylmethylphosphinate).
Grisley J. Am. Chem. Soc., 82, 423 (1960)).Grisley J. Am. Chem. Soc., 82, 423 (1960)).
(Harwbod and CH3 O fl CH3 O *\\ u P-OCH3 + PCIS O /// i Ph - _ Ph Ett lämpligt kärl utrustat med omrörare, kondensor, temperaturmätningsanordning och beskicktningsanordning beskickades med 187 delar metylfenylmetylfosfinat och 1600 delar koltetraklorid.Harwbod and CH3 O fl CH3 O * \\ u P-OCH3 + PCIS O /// i Ph - _ Ph A suitable vessel equipped with a stirrer, condenser, temperature measuring device and loading device was charged with 187 parts of methylphenylmethylphosphinate and 1600 parts of carbon tetrachloride.
Till denna blandning sattes 229 delar fosforpentakloríd i tre portioner om vardera 50 delar och en portion om 79 delar. En tem- peraturstegring observerades vid tillsatsen av de tre första por- tionerna. Blandníngen omrördes vid ungefär 60°C-under två timmar och därefter avdestillerades koltetrakloriden och fosforoxikloriden. Ãterstoden destillerades och man uppsamlade en fraktion med destil- larionsintervall 1ss-141°c/17 mm Hg. (952: utbyta av mefylfenylfos- finklorid). (Methoden Der Organishen Chemie (Houben-Weyl) Vol.To this mixture was added 229 parts of phosphorus pentachloride in three portions of 50 parts each and one portion of 79 parts. An increase in temperature was observed with the addition of the first three portions. The mixture was stirred at about 60 ° C for two hours and then the carbon tetrachloride and phosphorus oxychloride were distilled off. The residue was distilled and a fraction with distillation range 1ss-141 ° c / 17 mm Hg was collected. (952: replacement of mephylphenylphosphine chloride). (Methods of Organic Chemistry (Houben-Weyl) Vol.
XII/I p. 243). ca :H3 O _ CH3 _ cH3\\o 3 * ^ //É-cl +. s_ Q __lfE1fi, /,É“)-o : Ph fl a . Ph CH - § ' ' /CH\ _ i / \ CH CH CH3 CH; 3 3 . - ! Ett lämpligt kärl utrustat med omrörare, kondensor, temperaturmätningsanordning och beskicktningsanordning beskickades med 78 delar 1-mentol QExJâ5= -500 i etanol) och 72 delar dietyl- eter. Till den så erhållna lösningen sattes 119 delar trietylamín och blandningen kyldes till ungefär 0°C. Till blandningen sattes under omrörning 87 delar netylfenylfosfinklorid under loppet av ungefär 1,5 timmar medan temperaturen hölls vid ungefär 0°C. 10 15 20 25 V '30 35 40 ' i i eveooss-s-a -14 Élandningen fick stå,till dess att temperaturen stigit till unge- fär 25°C, varpå den upphettades under återflöde under ungefär IOQS timmar. l I - - Trietylaminhydrokloriden avfiltrerades från blandningen och filtratet koncentrerades. Härvid erhölls en fast substans, som smälte vid 50-65°C och som visade sig vara en blandning av Xßmentyl metylfenylfosfinat-diastereoisomerer (60% S och 40% R).XII / I p. 243). ca: H3 O _ CH3 _ cH3 \\ o 3 * ^ // É-cl +. s_ Q __lfE1 fi, /, É “) - o: Ph fl a. Ph CH - § '' / CH \ _ i / \ CH CH CH3 CH; 3 3. -! A suitable vessel equipped with a stirrer, condenser, temperature measuring device and loading device was charged with 78 parts of 1-menthol QExJâ5 = -500 in ethanol) and 72 parts of diethyl ether. To the solution thus obtained was added 119 parts of triethylamine and the mixture was cooled to about 0 ° C. To the mixture was added with stirring 87 parts of methylphenylphosphine chloride over the course of about 1.5 hours while maintaining the temperature at about 0 ° C. 10 15 20 25 V '30 35 40 'i i eveooss-s-a -14 The landing was allowed to stand until the temperature rose to about 25 ° C, after which it was heated under reflux for about 10 hours. The triethylamine hydrochloride was filtered off from the mixture and the filtrate was concentrated. This gave a solid which melted at 50-65 ° C and which was found to be a mixture of X-menthyl methylphenylphosphinate diastereoisomers (60% S and 40% R).
Den på ovan angivet sätt framställda blandningen av I-mentyl-metylfenylfosfinat-diastereoisomerer uppdelades i sina komponenter genom kristallisation flera gånger i hexan och kristal- lisation i dietyleter och man erhöll en fast substans, som smälte vid 78-82°C och som visade sig vara S-formen av ÅLmentyl-metyl- fenylfosfinat . cnš Ph 0 Ph\\0 ) \nx) "x v g P -o +- cæäcnzcnzxugsr ___; /P _ CHZCHZCHB Cfls CH _ CH: _ / \ g C33 cH3 .The mixture of 1-menthyl-methylphenylphosphinate diastereoisomers prepared as above was partitioned by crystallization several times in hexane and crystallization in diethyl ether to give a solid, melting at 78-82 ° C and showing be the S-form of ÅLmentyl methylphenylphosphinate. cnš Ph 0 Ph \\ 0) \ nx) "x v g P -o + - cæäcnzcnzxugsr ___; / P _ CHZCHZCHB C fl s CH _ CH: _ / \ g C33 cH3.
Ett lämpligt kärl utrustat med en omrörare, en tempera- turmätningsanordning, en beskioktningsanordning och en kondensor beskickades med en inert kväveatmosfär och därefter med 9,5 delar magnesium, 7 delar dietyleter och en reaktionsinitierande mängd jod. En liten mängd brompropan tillsattes för att initiera reak- tionen, varpå en blandning bestående av 47 delar brompropan och l23 delar dietyleter långsamt tillsattes med en sådan hastighet, att mild återflödeskokning av reaktionsblandningen upprätthölls.A suitable vessel equipped with a stirrer, a temperature measuring device, a coating device and a condenser was charged with an inert nitrogen atmosphere and then with 9.5 parts of magnesium, 7 parts of diethyl ether and a reaction initiating amount of iodine. A small amount of bromopropane was added to initiate the reaction, whereupon a mixture consisting of 47 parts of bromopropane and 233 parts of diethyl ether was slowly added at such a rate that mild refluxing of the reaction mixture was maintained.
Reaktionsblandningen kyldes därefter till ungefär 25°C och omrör- des under ytterligare två timmar.The reaction mixture was then cooled to about 25 ° C and stirred for an additional two hours.
Till denna blandning sattes en blandning bestående av 12 delar av S-form av-Ätmentyl-metylfenylfosfinat (framställt på ovan angivet sätt) och 88 delar bensen. Dietyletern avlägsnades därefter och den så erhållna blandningen upphettades vid 78°C ' under 64 timmar. ' -Magnesiumkomplexreaktibnsprodukten sönderdelades med en lösning av ammoniumklorid och filtrerades därefter. Fällningen extraherades med het bensen och extraktet kombinerades med filtra- tet. Det organiska skiktet torkades över natriumsulfat och lös- ningsmedlen avlägsnades, varigenom man erhöll en gul olja. Denna kronatograferades på en kiseldioxidgelkolonn men en blandning av 10 15 20 30 UJ UI '79003f55-h i «- '15 hexan:bensen:dietyleter (3:l:l), varigenom man erhöll en optiskt D aktiv fenylmetylpropylfosfinoxíd i 61% utbyte.To this mixture was added a mixture consisting of 12 parts of S-form of-Ethmentyl-methylphenylphosphinate (prepared as above) and 88 parts of benzene. The diethyl ether was then removed and the mixture thus obtained was heated at 78 ° C 'for 64 hours. The magnesium complex reactive product was decomposed with a solution of ammonium chloride and then filtered. The precipitate was extracted with hot benzene and the extract was combined with the filtrate. The organic layer was dried over sodium sulfate and the solvents were removed to give a yellow oil. This was chromatographed on a silica gel column but a mixture of hexane: benzene: diethyl ether (3: 1: 1) to give an optically active phenylmethylpropylphosphine oxide in 61% yield.
Ph 0 Ph O \\“X) CH cn CH + Hsicl + st N ----> \\Éx) cn CH c P ” 2' 2' 3 3 3 ,/ * 2 2 H3 CH3 ons Ett lämpligt kärl, som beskickats med en inert kväve- atmosfär och som var utrustat med omrörare, temperaturmätnings- anordning och beskicktningsanordning, beskickades med 16 delar triklorsilan och 88 delar bensen vid en temperatur av ungefär OOC.Ph 0 Ph O \\ “X) CH cn CH + Hsicl + st N ----> \\ Éx) cn CH c P” 2 '2' 3 3 3, / * 2 2 H3 CH3 ons A suitable vessel, which was charged with an inert nitrogen atmosphere and which was equipped with a stirrer, temperature measuring device and charging device, was charged with 16 parts of trichlorosilane and 88 parts of benzene at a temperature of about 0 ° C.
Till denna blandning sattes vid en temperatur av ungefär 4-6°C en blandning bestående av 22 delar trietylamin och 44 delar bensen.To this mixture was added at a temperature of about 4-6 ° C a mixture consisting of 22 parts of triethylamine and 44 parts of benzene.
Den så erhållna blandningen värmdes därefter till ungefär 25°C och en blandning av 8,2 delar optiskt aktiv fenylmetylpropyl- fosfinoxid (som framställts på ovan angivet sätt) och 22 delar bensen tillsattes. Blandningen upphettades därefter till ungefär_ 6o°c under loppet av två timma: och kyldes därefter till ungefär 2s°c. , Den som reaktionsprodukt erhållna kiselkomplexen sönder- delades med 75 delar av en 20% lösning av natriumhydroxid och därefter med 35 delar vatten. Den så erhållna blandningen fick ' stå ungefär 15 timmar, varpå den uppdelade;sig i skikt. Det orga- niska skiktet extraherades med 5% saltsyra, två gånger med vatten och torkades därefter över natriumsulfat. Lösningsmedlet avdestil- lerades och man erhöll metylpropylfenylfosfin i 95% utbyte med 69% optisk renhet.The mixture thus obtained was then heated to about 25 ° C and a mixture of 8.2 parts of optically active phenylmethylpropylphosphine oxide (prepared as above) and 22 parts of benzene were added. The mixture was then heated to about 60 ° C over two hours: and then cooled to about 2 ° C. The silica complexes obtained as a reaction product were decomposed with 75 parts of a 20% solution of sodium hydroxide and then with 35 parts of water. The mixture thus obtained was allowed to stand for about 15 hours, after which it was divided into layers. The organic layer was extracted with 5% hydrochloric acid, twice with water and then dried over sodium sulfate. The solvent was distilled off, and methylpropylphenylphosphine was obtained in 95% yield with 69% optical purity.
Ett sätt att framställa rodium(III)klorid-tris-(metyl- propylfenylfosfin) beskrives här nedan: Ett lämpligt kärl innehållande kväveatmosfär beskickades med 0,342 g (0,00l3 mol) rodium(III)klorid-trihydrat och 10 ml metanol, varpå 0,76 g (Ö,OO46 mol) av det på ovan angivet sätt framställda, optiskt aktiva metylpropylfenylfosfinet i 3 ml metanol tillsattes droppvis under loppet av 15 minuter- Blandningen fick stå under en timme, varunder en gul fällning bildades. Denna av- filtrerades och man erhöll 0,21 g av rodiumkomplexefi med specifik vridning MÉS= -69,2°(en blandning av 'bensen och etanol i volym- förhållandet 1:1).A process for preparing rhodium (III) chloride tris- (methylpropylphenylphosphine) is described below: A suitable vessel containing a nitrogen atmosphere was charged with 0.342 g (0.00l3 mol) of rhodium (III) chloride trihydrate and 10 ml of methanol, whereupon 0 .76 g (1.0646 mol) of the optically active methylpropylphenylphosphine prepared in the above manner in 3 ml of methanol were added dropwise over 15 minutes. The mixture was allowed to stand for one hour, during which time a yellow precipitate formed. This was filtered off and 0.21 g of rhodium complex fi with specific rotation MÉS = -69.2 ° (a mixture of benzene and ethanol in a volume ratio of 1: 1) was obtained.
Genom koncentration av filtratet erhölls ytterligare 0,13 g av rodukten med s ecifik vridning oz 25= -56,4° en blandning av P P _D bensen och etanol i volymförhållandet 1:1). 10 15 20 25 35 . 790035541 716 Exempel 2: Det i exempel l beskrivna allmänna förfarandet upprepa- des och blandningen av Åëmentyl-metylfenylfosfinat-diastereo- isomererna spaltades genom krístallisation i hexan och/eller hexan- eter, varigenom man erhöll en S-form, som smälte vid.78-82°C och hade specifik vridning -94°(bensen) och en R-form, som smälte vid 86-8?°C och hade specifik vridningÅ%äš5= -l7°(bensen). r oH3 ccH3_ ~- p _ l o _ Mgßr Ph o Ph - Fx) _ o S _ + ---+> \\§x)' i-CH i 1/ i / \ CH 3 O CH3 CH3 _ Cflš/ 7 Ett lämpligt kärl utrustat med omrörare, temperaturmät- ningsanordning, beskicktningsanordning och kondensor beskickades med inert kväveatmosfär och med 18,3 delar magnesiumsvarvspån, 14 delar dietyleter och en reaktionsinitierande mängd jod. En liten mängd o-anisylbromid tillsattes för initiering av reaktionen och därpå tillsattes långsamt en blandning av 138 delar o-bromanisol och 400 delar dietyleter med sådan hastighet, att mild återflödes- kokning upprätthålls. Sedan tillsatsen tillförts kokades bland- ningen under återflöde ytterligare två timmar._ .Concentration of the filtrate gave an additional 0.13 g of the product with specific rotation (= -56.4 ° a mixture of P (D-benzene and ethanol in a volume ratio of 1: 1). 10 15 20 25 35. Example 2: The general procedure described in Example 1 was repeated and the mixture of the Elementyl methylphenylphosphinate diastereoisomers was cleaved by crystallization from hexane and / or hexane ethers to give an S-form, melting at 78 ° C. -82 ° C and had specific rotation -94 ° (benzene) and an R-shape, which melted at 86-8 ° C and had specific rotationÅ% äš5 = -17 ° (benzene). r oH3 ccH3_ ~ - p _ lo _ Mgßr Ph o Ph - Fx) _ o S _ + --- +> \\ §x) 'i-CH i 1 / i / \ CH 3 O CH3 CH3 _ C fl š / 7 A suitable vessel equipped with a stirrer, temperature measuring device, loading device and condenser was charged with an inert nitrogen atmosphere and with 18.3 parts of magnesium turnings, 14 parts of diethyl ether and a reaction-initiating amount of iodine. A small amount of o-anisyl bromide was added to initiate the reaction, and then a mixture of 138 parts of o-bromoanisole and 400 parts of diethyl ether was slowly added at such a rate that mild refluxing was maintained. After the addition was added, the mixture was refluxed for a further two hours.
Till blandningen sattes en blandning bestående av 74 delar av antingen R- eller S-formen av Åtmentyl-metylfenylfosfinat (val av S- eller R-formen beror på vilken enantiomer som önskas erhållen genom den asymmetriska hvdreringen) och 450 delar bensen. Dietyl- etern avlägsnades därefter och blandningen upphettades vid 78°C under 64 timmar. I _ _i ' Det som reaktionsprodukt erhållna magnesiumkomplexet sönderdelades med en lösning av ammoniumklorid och produkten ~ extraherades ur vattenfasen med bensen. Sedan bensenen avlägsnats I destillerades den som återstod erhållna oljan, varvid man först avlägsnade en mentolfraktion. slutligen destillerade produkten över vid 180-l90°C/0,5 mm Hg. Den råa metylfenyl-o-anisylfosfinoxíden 'bildades i 60% utbyte. Vid användning av R-formen erhölls en produkt med specifik vridning EkJâ5= 427°(metanol). Vid användning gav S-formen erhölls en produkt med motsatt vridning. 790035544 10 15 20 .I- CJ . 17 ocu o 3 Ph\ cHso Il Ph -l x)_.© + Hslcla + staN ___; /P°“)_@ C113 , g C143 Ett lämpligt kärl innehållande inert kväveatmosfär och utrustat med omrörare, temperaturmätningsanordning och beskickt- ningsanordning beskickades med 16 delar triklorsilan och 100 delar bensen vid en temperatur av ungefär 5°C. Till blandningen sattes vid 4-6°C en blandning av 12 delar trietylamin och 50 delar bensen.To the mixture was added a mixture consisting of 74 parts of either the R or S form of Atmentyl methylphenylphosphinate (choice of the S or R form depends on which enantiomer is desired to be obtained by the asymmetric hydrogenation) and 450 parts of benzene. The diethyl ether was then removed and the mixture was heated at 78 ° C for 64 hours. The magnesium complex obtained as a reaction product was decomposed with a solution of ammonium chloride and the product was extracted from the aqueous phase with benzene. After the benzene was removed, the remaining oil was distilled, first removing a menthol fraction. finally, the product distilled over at 180-190 ° C / 0.5 mm Hg. The crude methylphenyl-o-anisylphosphine oxide was formed in 60% yield. Using the R-form, a product with specific rotation was obtained EkJâ5 = 427 ° (methanol). In use, the S-form gave a product with opposite rotation. 790035544 10 15 20 .I- CJ. 17 ocu o 3 Ph \ cHso Il Ph -l x) _. © + Hslcla + staN ___; A suitable vessel containing an inert nitrogen atmosphere and equipped with a stirrer, temperature measuring device and loading device was charged with 16 parts of trichlorosilane and 100 parts of benzene at a temperature of about 5 ° C. To the mixture was added at 4-6 ° C a mixture of 12 parts of triethylamine and 50 parts of benzene.
Den så erhållna blandningen uppvärmdes till 70°C och en blandning av 7,5 delar optiskt aktiv metylfenyl-o-anisylfosrinoxid i 30 delar bensen tillsattes. Blandningen upphettades till 70°C under en timme och kyldes därefter till 25°C. q Den som reaktionsprodukt erhållna kiselkomplexen sönder- delades genom tillsats under kväve av 75 delar av en 20% natrium- hydroxidlösning vid 25°C under kylning. Det önskade mety1fenyl-o- anisylfosfinet erhölls ur det organiska skiktet. Det hade specifik vridning EK]â5= +4l° (metanol) när den på ovan angivet sätt fram- ställda fosfinoxiaen med specifik vridning [fxÉÄ +27° (metanol) användes. Vid användning av den motsatta enantiomeren av fosfin- oxiden erhölls fosfin med motsatt vridning.The mixture thus obtained was heated to 70 ° C and a mixture of 7.5 parts of optically active methylphenyl-o-anisylphosphine oxide in 30 parts of benzene was added. The mixture was heated to 70 ° C for one hour and then cooled to 25 ° C. q The silica complexes obtained as a reaction product were decomposed by the addition under nitrogen of 75 parts of a 20% sodium hydroxide solution at 25 ° C under cooling. The desired methylphenyl-o-anisylphosphine was obtained from the organic layer. It had a specific rotation EK] 55 = + 41 ° (methanol) when the specific rotation of the phosphinoxia prepared in the manner indicated above (e.g. + 27 ° (methanol) was used. Using the opposite enantiomer of the phosphine oxide, phosphine was obtained with reverse rotation.
Exemnel'3: Framstallning_av metylcyklohexyl-o-anisylfosfin 0 ocn3 0 ocn3 '-'-'\ pg, \ + H 5% Rn/c - 3); \\ LW / / - 2 á I J\-_-/ C143 C113 En enliters autoklav beskickades med 143 delar av den på ovan angivet sätt framställda (+)-metylfenyl-o-anisylfosfinoxiden, 28 delar 5% rodium på kol och 250 delar metanol- Satsen upphetta- des till 75°C och omrördes_under en väteatmosfär med ett tryck av 56 kp/cmz övertryck. När_väteupptagningen upphörde visade NMR-- spektrum att den i den ovan ätergivna ekvationen beskrivna reak- tionen försiggått till 75%. En ytterligare mängd om 7,0 delar katalysator tillsattes, satsen sattes åter igen under vätgastryck 56 kp/cmz övertryck och reaktionen fortsattes till en omsättning av 96%- vakuum. Den råa oljan upptogs i 200 delar dibutyleter och kyldes till OOC. Kristallerna som utföll avfiltrerades och tvättades med Katalysatorn avfiltrerades och metanolen avdrevs under .i »- 10 20 25 .3cl>_ _ 40 7900355 - år -Ä'48 hexan. Man erhöll_pa detta sätt 63 delar metylcyklohexyl-o-anisy1- fosfinoxid, som smälte vid 108-llO°C och hade specifik vridning EX.šO= +63q (metanol). a _ _ Den på ovan angivet sätt framställda fosfinoxiden kan reduceras till metylcyklohexyl-o-anisylfosfin i 95% utbyte med an- vändning av HSiCl3 och trietylamin på sätt som angives här ovan för metylfenyl-o-anisylfosfin_ Det erhållna metylcyklohexyl-o- anisylfosfínet är en vätska med specifik vridning EgJâo= +98,5° (metanol).Example '3: Preparation of methylcyclohexyl-o-anisylphosphine (Ocn3 and ocn3 '-'-' \ pg, \ + H 5% Rn / c - 3); A one liter autoclave was charged with 143 parts of the (+) - methylphenyl-o-anisylphosphine oxide prepared as above, 28 parts of 5% rhodium on carbon and 250 parts methanol- The batch was heated to 75 ° C and stirred under a hydrogen atmosphere with a pressure of 56 kp / cm 2 overpressure. When the hydrogen uptake ceased, the NMR spectrum showed that the reaction described in the equation given above proceeded to 75%. An additional 7.0 parts of catalyst was added, the batch was refluxed under hydrogen pressure of 56 kp / cm 2 and the reaction was continued to a 96% vacuum reaction. The crude oil was taken up in 200 parts of dibutyl ether and cooled to 0 ° C. The crystals which precipitated were filtered off and washed with the catalyst, filtered off and the methanol was evaporated off under hexane-4'4 hexane. There were thus obtained 63 parts of methylcyclohexyl-o-anisylphosphine oxide, which melted at 108 DEG-110 DEG C. and had a specific rotation EXS6 = + 63 DEG (methanol). The phosphine oxide prepared as above can be reduced to methylcyclohexyl-o-anisylphosphine in 95% yield using HSiCl 3 and triethylamine in the manner set forth above for methylphenyl-o-anisylphosphine. a liquid with specific rotation EgJâo = + 98.5 ° (methanol).
Exemgel 4: Asymmetrisk hydrering av-<-bensamido-4-hydroxi- 3-metoxi-kanelsyra _g En hydreringsapparat utrustad med tryckmätare, tempera- turmätningsanordning och upphettningsanordning beskickades med. 25 delar oš-'bensamido-LL-hydroxi-B-metoxi-kanelsyra, 186 delar meta- nol och 64 delar 5% natriumhydroxíd. Satsen renblåstes omsorgsfullt för avlägsnande av varje spår av luft och vätgastrycket inställdes slutligen på 3,5 kp/cm? övertryck och temperaturen på 25°C.Example 4: Asymmetric hydrogenation of - <- benzamido-4-hydroxy-3-methoxy-cinnamic acid _g A hydrogenation apparatus equipped with pressure gauge, temperature measuring device and heating device was loaded with. 25 parts of β-benzamido-LL-hydroxy-β-methoxy-cinnamic acid, 186 parts of methanol and 64 parts of 5% sodium hydroxide. The batch was carefully blown to remove each trace of air and the hydrogen pressure was finally set at 3.5 kp / cm? overpressure and the temperature of 25 ° C.
En katalysatorlösning framställdes genom upplösning av 0,0059 9 ;0dium_1¿5-hexadienklorid (Låh(lQ5-hexadien)ClI2) J] Am. Chem. Soc. 86,217 (1964) i 2 ml bensen under kväveatmosfär.A catalyst solution was prepared by dissolving 0.0059 g of sodium 1,5-hexadiene chloride (Low (10 -5-hexadiene) Cl 2) J] Am. Chem. Soc. 86,217 (1964) in 2 ml of benzene under a nitrogen atmosphere.
Därefter tillsattes 0,0l39 g (+)-metylfenyl-o-anisylfosfin i 1,3 ml bensen, varpå väte.leddes genom blandningen under fem minuter. Den så erhållna katalysatorldsningen inpressades därefter-i en autoklav med vätetryck. Hydreríngen började omedelbart och var avslutadi efter 3-4 timmar vid ZSOC och 3,5 kp/cm? övertryck.Then 0.039 g (+) - methylphenyl-o-anisylphosphine in 1.3 ml of benzene was added, then hydrogen was passed through the mixture for five minutes. The catalyst solution thus obtained was then pressed into an autoclave with hydrogen pressure. The hydration started immediately and ended after 3-4 hours at ZSOC and 3.5 kp / cm? overpressure.
~Analys av den så erhållna lösningen visade en optisk ren- het av 56,4% svarande mot en L/D-blandning av natriumsaltet av "N-bensoyl-3-(4-hydroxi-3-metoxifenyl)-alanin i mängdförhållandet 78:22.Analysis of the solution thus obtained showed an optical purity of 56.4% corresponding to an L / D mixture of the sodium salt of "N-benzoyl-3- (4-hydroxy-3-methoxyphenyl) -alanine in the amount ratio 78 : 22.
Den N-bensoylsubstituerade aminosyran kan framställas i 95% utbyte genom förångning av metanolen och neutralisation av natriumsaltet med saltsyra. F _ Den så erhållna L-enantiomeren kan omvandlas till L-DORA genom enkel hvdrolys för avlägsnande av de blockerande grupperna bensoyl och metyl på substituenten i 3-ställningen på fenylgruppen.The N-benzoyl-substituted amino acid can be prepared in 95% yield by evaporation of the methanol and neutralization of the sodium salt with hydrochloric acid. The L-enantiomer thus obtained can be converted to L-DORA by simple hydrolysis to remove the blocking groups benzoyl and methyl on the substituent in the 3-position of the phenyl group.
Exemgel 5: En enliters autoklav beskickades med 25,0 g1-bensamido- 4-hydroxi-3-metoxi-kanelsyra, 300 ml metanol och 0,6 ml 5% vatten- lösníng av NaOH. Satsen omrördes vid 25°C under 2,8 kp/cm?(över- tryck) av ren vätgas, till dess att det med säkerhet kunde konsta- teras att ingen läckning förekom. Ungefär l ml (0,0l% Rh, 0,05% vsoozšs-4 lO 15 20 25 19 fosfin) av följande katalysatorlösning tillsattes genom en skiljevägg utan att trycket avblåstes. Katalysatorlös- ningen hade framställts genom upplösning under N2 av 0,005O g [Én (1,5-hexadien)Gl72, smältPunkÜ 115-11700- elementaranalys: % C % H % Cl beräknat 52,58 4,57 15,08 funnet 52,41 4,41 15,82 i 0,55 ml av en lösning av metylfenyl-o-anisylfosfin [ESYÉE = +42° (metanol) med specifik vridning _/_5c 1235 = +42° (metanol) i bensen innehållande 0,041 g/ml och utspädning till 1 ml med metanol. Fosfinoxidförsteget hade en smält- punkt av 70-75°C, (jä/âO= +25,9° (metanol).Example 5: A one liter autoclave was charged with 25.0 g of 1-benzamido-4-hydroxy-3-methoxy-cinnamic acid, 300 ml of methanol and 0.6 ml of 5% aqueous solution of NaOH. The batch was stirred at 25 ° C below 2.8 kp / cm 2 (gauge pressure) of pure hydrogen gas, until it could be established with certainty that no leakage occurred. Approximately 1 ml (0.01% Rh, 0.05% phosphorus) of the following catalyst solution was added through a partition without depressurizing the pressure. The catalyst solution had been prepared by dissolving under N 2 of 0.005O g [One (1,5-hexadiene) Gl72, molten Punk® 115-11700 elemental analysis:% C% H% Cl calculated 52.58 4.57 15.08 found 52, 41 4.41 15.82 in 0.55 ml of a solution of methylphenyl-o-anisylphosphine [ESYÉE = + 42 ° (methanol) with specific rotation _ / _ 5c 1235 = + 42 ° (methanol) in benzene containing 0.041 g / ml and dilute to 1 ml with methanol. The phosphine oxide precursor had a melting point of 70-75 ° C, (α / D = + 25.9 ° (methanol).
Omrörning med 1400 varv per minut upprätthölls i reaktionsmassan och väte började absorberas efter 2-5 minuters induktíonstid. Hydreringen var slutförd på 2 timmar.Stirring at 1400 rpm was maintained in the reaction mass and hydrogen began to be absorbed after 2-5 minutes of induction time. The hydrogenation was completed in 2 hours.
Metanolen avdrevs och syran löstes i en mol av en vattenlösning av Na0H. Den neutrala katalysatorn extra- herades med bensen och ställdes undan för utvinning. Den fria aminosyran fälldes därefter genom tillsats av kon- centrerad H01 under riklig ympning. Man erhöll 24 g N- bensoyl-5-(4-hydroxi-5-metoxífenyl)-alanin innehållande 75 % av Ifenantiomeren och 27 % av D-enantiomeren. If enantiomeren kan omvandlas till IFDOPA genom hydrolys på sätt som angives i exempel 4.The methanol was evaporated and the acid was dissolved in one mole of an aqueous solution of NaOH. The neutral catalyst was extracted with benzene and set aside for recovery. The free amino acid was then precipitated by the addition of concentrated H01 with copious inoculation. 24 g of N-benzoyl-5- (4-hydroxy-5-methoxyphenyl) -alanine containing 75% of the Ifenantiomer and 27% of the D-enantiomer were obtained. If the enantiomer can be converted to IFDOPA by hydrolysis in the manner set forth in Example 4.
Exempel 6-21: Andra optiskt aktiva a-aminosyror framställ- des pà sätt liknande dem som angives i exemplen 4 och 5 med användning av en katalysator innehållande rodium- 1,5-hexadienklorid och fosfinligand med strukturformeln /cnš R-PX G Exemplen är sammanställda i nedanstående tabell: 7900355-4 420 Hhmfiflmlo WU .Q m\ww|wæ ax |~muwmonmu :N: max m . EUÅX oønflm fløæwflfl .R .vwScwH.MwflvnO mmsS\o°mx anopmmhfimuwm umpmø .mhh _ m _ïOOU:IU| EU ^x OHU :J zoou|zu«mmu PMSUOHQ ZZ. _ ._ N IOOUIUN ÉU nflMwaO 79003554t 24 Ömmfiflå å RAK. mä . Û mmolo NH Qwwlww AE Rmommommu w Qææéw .ä -mmummummo & .umflflwn oofiëmaa Hovmwhæmvmx äflå wmssšvomx “mnmu .mmm ¶ _ møoomu- man] xlv AM \.Examples 6-21: Other optically active α-amino acids were prepared in a manner similar to those set forth in Examples 4 and 5 using a catalyst containing rhodium 1,5-hexadiene chloride and phosphine ligand of the structural formula / cnš R-PX G The examples are compiled in the table below: 7900355-4 420 Hhm fifl mlo WU .Q m \ ww | wæ ax | ~ muwmonmu: N: max m. EUÅX oøn fl m fl øæw flfl .R .vwScwH.Mw fl vnO mmsS \ o ° mx anopmmh fi muwm umpmø .mhh _ m _ïOOU: IU | EU ^ x OHU: J zoou | zu «mmu PMSUOHQ ZZ. _ ._ N IOOUIUN ÉU n fl MwaO 79003554t 24 Ömm fifl å å RAK. mä. Û mmolo NH Qwwlww AE Rmommommu w Qææéw .ä -mmummummo & .um flfl wn oo fi ëmaa Hovmwhæmvmx ä fl å wmssšvomx “mnmu .mmm ¶ _ møoomu- man] xlv AM \.
/ HU _ EZ mooušummu ^X Påäfiønß :ooo »una \ f _ OHU _ EZ f _ _ mooowökmu Ü mooofoumu x ._ mmu _ O" _ mz _N./ HU _ EZ mooušummu ^ X Påä fi ønß: ooo »una \ f _ OHU _ EZ f _ _ mooowökmu Ü mooofoumu x ._ mmu _ O" _ mz _N.
EOOUIUM SU CHHQAO fiwmåwxm 79003594! _22 m.«fl m\æw|ww ax zwzumzommu Hhmfinmlo mv _ mß|oß @sw_ @ø@@o _ m:o|o _ & .pwflflwfi Oonflm uovmmäfldvøx wmsa\v°@x xmfipmo . _ "mßæu .mmm _m_ _ _ _ ___ m mo _ _ mo _ _ _ _ _ _ _ _ _ ouu __ _ _ _ uu _ _ ___ _ _ _ az _ mz _ _ _ :ooo1flu«w:u«1A߶W :oou«uuæu«1A1Lv x _ 1. _ _ mmm _. _ _ mmo _ _ ouo ouu _ _ _ _ _ mz _mz _ :_ _ w _ _ _; _ moouàu- mo l® moouónmu MÜ un _ _ _ _ «xsvo»m nfiwwflo Hwmñmxm 79Û03155~'~*t 25 mm mm ^floQm»mSv o@«w~\+ n %\flN wmvmnmw o aøfiwcflwwwom.EOOUIUM SU CHHQAO fi wmåwxm 79003594! _22 m. «Fl m \ æw | ww ax zwzumzommu Hhm fi nmlo mv _ mß | oß @sw_ @ ø @@ o _ m: o | o _ & .pw flfl w fi Oon fl m uovmmä fl dvøx wmsa \ v ° @ x xm fi pmo. _ "mßæu .mmm _m_ _ _ _ ___ m mo _ _ mo _ _ _ _ _ _ _ _ _ _ ouu __ _ _ _ uu _ _ ___ _ _ _ az _ mz _ _ _: ooo1 fl u« w: u «1Aß ¶W: oou «uuæu« 1A1Lv x _ 1. _ _ mmm _. _ _ Mmo _ _ ouo ouu _ _ _ _ _ mz _mz _: _ _ w _ _ _; _ moouàu- mo l® moouónmu MÜ un _ _ _ _ «Xsvo» m n fi ww fl o Hwmñmxm 79Û03155 ~ '~ * t 25 mm mm ^ fl oQm »mSv o @« w ~ \ + n% \ fl N wmvmnmw o aø fi wc fl wwwom.
Afioflmpmfiv omxyfiowwå Hßxwn sofixho IÛ N m m\ww»ww mm :mo mo mu R , ßwflflmh xmfipmo ofasw. wmss\o°@x nmvæw .mhß Hovmm>fimvmM OHO _ EZ _ EOOUIEUI ^X _ $OOU|IO| AX mæu|¿@íLwwom . m O vxnøonm O EU å. mmu mooo|unmu|A@Lw|om _vfl ¶. m ÛH _ .EZ . _ EOOUiUHmU mflwwflo O SU 79010355 - 1» 4 _ __ 2. om m\o@ mg :ßv|mßv nam wouwnww v.v lvflxonflwmow 0 män _ N .vmnflmn 0 ._ xmflpmo wmaa\v°@M uwnmfl .whh flhmonmomfi \\\ U 30 flwnwvmmfloxnm Hovmwaamvmx _ _ :ooo|:o|mmo|Å@L%w|o: nu _ mz _ZOOUr$O| Ax.A fi o fl mpm fi v omxy fi owwå Hßxwn so fi xho IÛ N m m \ ww »ww mm: mo mo mu R, ßw flfl mh xm fi pmo ofasw. wmss \ o ° @ x nmvæw .mhß Hovmm> fi mvmM OHO _ EZ _ EOOUIEUI ^ X _ $ OOU | IO | AX mæu | ¿@ íLwwom. m O vxnøonm O EU å. mmu mooo | unmu | A @ Lw | om _v fl ¶. m ÛH _ .EZ. _ EOOUiUHmU m fl ww fl o O SU 79010355 - 1 »4 _ __ 2. om m \ o @ mg: ßv | mßv nam wouwnww vv lv fl xon fl wmow 0 men _ N .vmn fl mn 0 ._ xm fl pmo wmaa \ v ° @ M um fi \ h. \ U 30 fl wnwvmm fl oxnm Hovmwaamvmx _ _: ooo |: o | mmo | Å @ L% w | o: nu _ mz _ZOOUr $ O | Ear.
O EU mmoxA@Lw1o:_ _ m o mu _wx=uoHm .Ofln_v _ :%_ _ _ møou|uumu.1Q@m|.oa __@« _ _ ommu _ ouu _ _, ._ mz _ _ _ / . u u . moou;onmu|¿®@@w|_om mfi __ _ ommu _ cfiwwfio AM Ewxu ~_7soozss~a 25 Aflbflmvmëv m.æ+nowNww mßnww nam wøvmnfim uwfiwonfiwwom v.o .wo.o\omv ax Aflmdflouv .. °«w+nm\w\ w vo.ø\m@|om ax & .pmflflwh oamüm mmfipmo wmaa\o°@x "mvmfl .whh -íu mmwmwflfldvmx Oš _ N IOOU|EO1 EU ^X ouu _ mz _ ¶ moou|mu|Nmu|^@>@W|om . Aon IL@ií¶Y|O$ N O EU ommo #¥flUOHm .|.||||||||||||l||- . .lalnsll lo.. 1 Plr! wa _ ud 7900555 - 4 ...f NN.O EU mmoxA @ Lw1o: _ _ m o mu _wx = uoHm .O fl n_v _:% _ _ _ møou|uumu.1Q@m|.oa __ @ «_ _ ommu _ ouu _ _, ._ mz _ _ _ /. u u. moou; onmu | ¿® @@ w | _om m fi __ _ ommu _ c fi ww fi o AM Ewxu ~ _7soozss ~ a 25 A fl b fl mvmëv m.æ + nowNww mßnww nam wøvmn fi m uw fi won fi wwom vo .wo.o \ omv ax A fl md ° \ w \ w vo.ø \ m @ | om ax & .pm flfl wh oamüm mm fi pmo wmaa \ o ° @ x "mvm fl .whh -íu mmwmw flfl dvmx Oš _ N IOOU | EO1 EU ^ X ouu _ mz _ ¶ moou | mu | Nmu | ^ @> @ W | om. Aon IL @ ií¶Y | O $ NO EU ommo # ¥ fl UOHm. |. ||||||||||||||| l || -. .Lalnsll lo .. 1 Plr! Wa _ ud 7900555 - 4 ... f NN.
Hhwwnmuo om mß|oß man mmoè mä mß»oß gsm x .fiimmp ooêæ _ Éæwfl xwflmo wmsašomx Jääwhfimpmm "mumw . mhm .au o ÄH _ moou|mo|~mo|mo _ _ O" m \\N0 /mmu 1 ma _ \. . mooofmmïmfiwoëlfiïwmmo mm O...u -o-o o\ Ouæ .MZ _ _ _ moøflïmohwolmom _ _ Q ommo »xøuon ..1:| 11.: 0% _ _ _ m É \mo møouuwumnïmo/ ä _ mms ß _ 0% mmm _ _ o _ mz _ .moovfïmofuñïwmmo _ om _ . . _ ø oi.. ä __ _ moonflonmvüom E, _ ømmu_ . . .mw%flwummm f!r||.|.l. .En .Iilv Än!! -|.||_ v 'zeoozss-a i _ 27 10 45 20 25 50 55 Exempel 22: En autoklav beskickades med 25,0 g (0,085 mol) a-acetamido-4-hydroxi-3-metoxi-kanelsyraacetat, 300 ml metanol och 0,56 ml 50 % Na0H. Autoklaven sattes under ett tryck av 2,46 kp/omg övertryck med en blandning av Nä och H2 (50: 50).Hhwwnmuo om mß | oß man mmoè mä mß »oß gsm x .fi immp ooêæ _ Éæw fl xw fl mo wmsašomx Jääwh fi mpmm" mumw. Mhm .au o ÄH _ moou | mo | ~ mo | mo _ _ O "m \\ N0 / mmu 1 ma _ \. . mooofmmïm fi woël fi ïwmmo mm O ... u -o-o o \ Ouæ .MZ _ _ _ moø fl ïmohwolmom _ _ Q ommo »xøuon ..1: | 11 .: 0% _ _ _ m É \ mo møouuwumnïmo / ä _ mms ß _ 0% mmm _ _ o _ mz _ .moovfïmofuñïwmmo _ om _. . _ ø oi .. ä __ _ moon fl onmvüom E, _ ømmu_. . .mw% fl wummm f! r ||. | .l. .En .Iilv Än !! Example 22: An autoclave was charged with 25.0 g (0.085 mol) of α-acetamido-4-hydroxy-3-methoxy-cinnamic acid acetate, 300 ml methanol and 0.56 ml 50% NaOH. The autoclave was placed under a pressure of 2.46 kp / rev overpressure with a mixture of Nä and H2 (50:50).
En katalysatorlösning framställdes genom upplösning av o,oo5o g (o,o25 mekv.) ¿ïíh(1,5-hexadien)c_1_72 i o,5 m1 bensen, varpå man under kväveatmosfär tillsatte 0,051 mekv. (+)- metylcyklohexyl-o-anisylfosfin (optisk renhet ca 90 %) i 2,4 ml bensen. Väte bubblades genom denna lösning under 10 minuter, Rhodiumf1,5-hexadienklorid, se exempel 4 och 5 här ovan. I > Ehn erhöll på detta sätt (+)metylcyklohexyl-o-anisyl- fosfin, vätskeformig, kokpunkt 11o-14L»°c/o,o9 mmHg fixjâfë +98,5° (c=4 i Me0H) vid 90 % optisk renhet [ä]%O= +89° (c=1 i'Me0H).A catalyst solution was prepared by dissolving 0.85 g (0.25 meq.) Of β (1,5-hexadiene) c_1_72 in 0.5 ml of benzene, then adding 0.051 meq under a nitrogen atmosphere. (+) - methylcyclohexyl-o-anisylphosphine (optical purity about 90%) in 2.4 ml of benzene. Hydrogen was bubbled through this solution for 10 minutes, Rhodium f1,5-hexadiene chloride, see Examples 4 and 5 above. In this way, Ehn obtained (+) methylcyclohexyl-o-anisylphosphine, liquid, boiling point 110 DEG-14 DEG C. ° C / 0.19 mmHg. [α]% O = + 89 ° (c = 1 in MeOH).
Katalysatorlösningen infördes därefter i autoklaven och hydreringen genomfördes vid 60°C. Den var slutförd på 4 tim- mar. Produkten, nämligen N-acetyl-5-(4-hydroxi-5-metoxi- fenyl)-alaninacetat, som utvanns genom förångning av lös- ningsmealet, hade specifik vridning zajšï +5e,2 (Na san; i vatten). Rent Nßacetyl-5-(4-hydroxi-5-metoxifenyl)-Ir alaninacetat, också i form av natriumsalt i vatten, hade specifik vridning /ä]å5= +54,0°. Den optiska renheten hos den erhållna hydreringsprodukten var sålunda 70,7 % eller bättre än 85 % av Irenantíomeren och 15 % av D-enantiomeren.The catalyst solution was then introduced into the autoclave and the hydrogenation was carried out at 60 ° C. It was completed in 4 hours. The product, namely N-acetyl-5- (4-hydroxy-5-methoxyphenyl) -alanine acetate, which was recovered by evaporation of the solution flour, had specific rotation zajšï + 5e, 2 (Na san; in water). Pure Nacetyl-5- (4-hydroxy-5-methoxyphenyl) -Ir alanine acetate, also in the form of sodium salt in water, had a specific rotation / λ] = + 54.0 °. Thus, the optical purity of the obtained hydrogenation product was 70.7% or better than 85% of the irenantiomer and 15% of the D-enantiomer.
Det ovan beskrivna förfarandet upprepades med (-)-metyl- cyklohexylfo-anisylfosfin (optisk renhet ca 80 %). Man erhöll en hydreringsprodukt innehållande en huvudmängd av D-enantio- meren (optisk renhet hos reaktionsproduktblandningen var 65 %). Genom lämpligt val av (+)- eller (~)-fosfinen kan man sålunda framställa respektive enantiomer i stort utbyte.The procedure described above was repeated with (-) - methylcyclohexylphoanisylphosphine (optical purity about 80%). A hydrogenation product containing a major amount of the D-enantiomer was obtained (optical purity of the reaction product mixture was 65%). Thus, by appropriate selection of the (+) or (~) phosphine, one can produce the respective enantiomers in large yield.
Exempel 25: Det i exempel 22 beskrivna förfarandet upprepa- des med användning av (-)-metylcyklohexyl-o-anisylfosfinen (optisk renhet ca 80 %) lå/šO= -?5,6° (c=1 i Me0H) som den optiskt aktiva liganden och a-bensamído~4-hydroxi~5-metoxi- kanelsyra som den B-substituerade a-acylamídoakrylsyran. Den erhållna hydreringsprodukten utgjordes av N~bensoyl-3-(4- hydroxi-5-metoxifenyl)-alanin innehållande en huvudmängd av 10 .qs 20 25 50 55 ,ExemQel 25: p, 28 mass-z.Example 25: The procedure described in Example 22 was repeated using the (-) - methylcyclohexyl-o-anisylphosphine (optical purity about 80%) was / šO = -? 5.6 ° (c = 1 in MeOH) as the optically active ligand and α-benzamido-4-hydroxy-5-methoxy-cinnamic acid as the B-substituted α-acylamidoacrylic acid. The hydrogenation product obtained consisted of N-benzoyl-3- (4-hydroxy-5-methoxyphenyl) -alanine containing a major amount of 10 .mu.g of 50 50, Example 25: p, 28 mass-z.
D-enantiomeren (optisk renhet hos reaktionsproduktbland- ningen cirka 65 %). 2 s Exempel 24: I en tryckkolv, som renblåsts med kväve, sat- sades u-bensamido-4-hydroxifš-metoxi-kanelsyra (1,6? g, 5,0 mol), cyklooktadien-4,5-bis(metylcyklohexyl-o-anisylfosfin) .iridiumtetrafluorborat,.klarröd, fast substans (21,7 mg, p 0,025 mol), ooh 20 ml vattenfri metanol. Blandningen omrördes och genombubblades med kväve i 45 minuter. Trycket i tryck- “kolven höjdes till 7.kp/cm? övertryck genom inblàsning av väte, ooh blandningen omrördes och upphettades vid 100°C i 4 timmar 20 minuter. En portion av denna reaktionsblandning underkastades NNE-spektrometrisk analys, varav det framgick att 59 % av utgångsmaterialet hade omvandlats till produkten Nëhensoyl-5-(4-hydroxi-5-metoxifenyl)-alanin. Genom poleri- metrisk analys av reaktionsblandningen efter neutralisation enligt standardförfaranden framgick det, att produkten var optiskt aktiv med [d]%4= 9,5°.The D-enantiomer (optical purity of the reaction product mixture about 65%). 2 s Example 24: In a pressure flask purged with nitrogen, u-benzamido-4-hydroxyphs-methoxy-cinnamic acid (1.6 μg, 5.0 mol), cyclooctadiene-4,5-bis (methylcyclohexyl) was charged -o-anisylphosphine), iridium tetrafluoroborate, clear red solid (21.7 mg, p 0.025 mol), and 20 ml of anhydrous methanol. The mixture was stirred and purged with nitrogen for 45 minutes. The pressure in the pressure piston was raised to 7.kp/cm? overpressure by blowing hydrogen, and the mixture was stirred and heated at 100 ° C for 4 hours 20 minutes. An aliquot of this reaction mixture was subjected to NNE spectrometric analysis, which showed that 59% of the starting material had been converted to the product Nëhensoyl-5- (4-hydroxy-5-methoxyphenyl) -alanine. Polymerometric analysis of the reaction mixture after neutralization according to standard procedures showed that the product was optically active with [d]% 4 = 9.5 °.
I en lösning av 2,005 g N-acetyl-indolyl-d- acetamidoacrylsyra i 60 ml metanol sattes 0,0074 g cyklo- oktadien -1,5-bis(metylcyk1ohexyl-o-anisylfosfin)rodiumtetra- fluorborat, orangefärgade kristaller med en smältpunkt av 17041?5°C. Den så erhållna massan renblåstes omsorgsfullt, i röret med kväve een därefter med väte, een emröraes därefter under ett väteövertryck av 2,7 kp/cm? vid 25°C, Hydreringen till N,N'-diacetyl-tryptofan slutfördes på 2,5 timmar. Iös- -ningen utspäddes till 400 ml och analyserades med avseende _pà optisk vridningsförmåga. Iösningen hade [&]ïP= 20,1°.To a solution of 2.005 g of N-acetyl-indolyl-d-acetamidoacrylic acid in 60 ml of methanol was added 0.0074 g of cyclooctadiene-1,5-bis (methylcyclohexyl-o-anisylphosphine) rhodium tetrafluoroborate, orange crystals with a melting point of 17041 - 5 ° C. The mass thus obtained was carefully blown clean, in the tube with nitrogen one then with hydrogen, one then stirred under a hydrogen overpressure of 2.7 kp / cm? at 25 ° C, The hydrogenation to N, N'-diacetyl-tryptophan was completed in 2.5 hours. The solution was diluted to 400 ml and analyzed for optical torsion. The solution had [&] ïP = 20.1 °.
Teoretiskt värde för den rena optiska enantiomorfen är 25,9°.Theoretical value for the pure optical enantiomorph is 25.9 °.
Man hade sålunda erhållit en optisk renhet av 77,5 %. Ero- dukten kan isoleras genom att lösningsmedlet föràngas och återstoden kristalliseras.Thus, an optical purity of 77.5% had been obtained. The product can be isolated by evaporating the solvent and crystallizing the residue.
Exempel 26: Optiskt aktivt metylpropylfenylarsin framställdes på sätt som angives av Nislow och medarbetare i JACS 25, 955 (1975) - En katalysatorlösning framställdes genom sammanblandning av 2 ml metanol, 0,2 g (+)-metylpropylfenylarsin (/ä]%P= å+10,?°, 80 %, 0,16 mmol) och 0,025 g rodium(oyklooktadien- 1,5)-acetonylaoetonat(0,08 mmol), smältpunkt 125-128°0 (sön- derdelning). Efter omrörning i 40 minuter under kväveatmosfär 79oozss+A 10 45 25 50 55 29 hade hela mängden fasta beståndsdelar gått i lösning. En lösning av 4,0469 g a-acetamido-4-hydroxi-5-metoxi-kanel- syraacetat i 25 ml metanol renblàstes omsorgsfullt med kväve och sattes därefter under ett väteövertryck av 3,9 kp/omg vid 50°C. Till reaktionsblandningen sattes genom ett septum 4,0 ml av den ovan angivna katalysatorlösningen. Hydreringen började och var slutförd på 2,5 timmar, vilket framgick av ett tryckfall om 0,8 kp/cmg. Den resulterande massan utspäd- des till 50 ml och provades med avseende på specifik optisk vridningsförmåga, som visade sig vara Zä]%P= ~2,55°. En testlösning med användning av rent N-acetyl-3(4-hydroxi-5- metoxi-fenyl)-Ifalaninacetat och samma mängd katalysator gav en korrektion av denna vridningsförmåga för katalysatorn av O,7°. Hydreringen gav sålunda en nettovridning av -1,8°.Example 26: Optically active methylpropylphenylarsine was prepared as described by Nislow and co-workers in JACS 25, 955 (1975) - A catalyst solution was prepared by mixing 2 ml of methanol, 0.2 g (+) - methylpropylphenylarsine (/ ä]% P = å + 10,? °, 80%, 0.16 mmol) and 0.025 g of rhodium (oyklooctadiene-1,5) -acetonylaoetonate (0.08 mmol), m.p. 125-128 ° 0 (dec.). After stirring for 40 minutes under a nitrogen atmosphere 79oozss + A 10 45 25 50 55 29 the whole amount of solids had gone into solution. A solution of 4.0469 g of α-acetamido-4-hydroxy-5-methoxy-cinnamic acid acetate in 25 ml of methanol was thoroughly purged with nitrogen and then placed under a hydrogen overpressure of 3.9 kp / omg at 50 ° C. To the reaction mixture was added through a septum 4.0 ml of the above catalyst solution. The hydrogenation began and was completed in 2.5 hours, as evidenced by a pressure drop of 0.8 kp / cmg. The resulting mass was diluted to 50 ml and tested for specific optical torque, which was found to be Za]% P = ~ 2.55 °. A test solution using pure N-acetyl-3- (4-hydroxy-5-methoxy-phenyl) -phalanine acetate and the same amount of catalyst gave a correction of this torsional ability of the catalyst of 0.7 °. The hydrogenation thus gave a net rotation of -1.8 °.
Den rena optiska enantiomorfen hade /d]%0= -40,8°. Den op- tiska renheten var således 4,4 %.The pure optical enantiomorph had / d]% 0 = -40.8 °. The optical purity was thus 4.4%.
Bevis för att arsinet icke var optiskt rent erhölls genom dess omvandling till sulfiden (Mislow och medarbetare i JACS 22, 955a(1975))och mätning av den optiska renheten med ett kemiskt förskjutningsreagens (NMR_Chira1 Shift Reagent, Whitesides och medarbetare JACS 2§, 4058 (1974)). Detta försök visade att det använda metylpropylfenylarsinet hade en optisk renhet av endast 45 %. Om sålunda hydreringen hade genomförts med det optiskt rena arsinet, hade en optisk renhet av-9,5 % uppnåtts. Genom avdrivning av metanolen och omkristallisation ur den koncentrerade lösningen utvanns produkten.Evidence that the arsine was not optically pure was obtained by its conversion to the sulfide (Mislow and co-workers in JACS 22, 955a (1975)) and measurement of the optical purity with a chemical shift reagent (NMR_Chira1 Shift Reagent, Whitesides and co-workers JACS 2§, 4058). (1974)). This experiment showed that the methylpropylphenylarcin used had an optical purity of only 45%. Thus, if the hydrogenation had been carried out with the optically pure arsine, an optical purity of -9.5% would have been achieved. Evaporation of the methanol and recrystallization from the concentrated solution recovered the product.
Exempel 22: Framställning av cyklooktadien-4,5-bis(metyl- cyklohexyl-o-anisylfosfin)-rodiumtetrafluorborat. I en 4- liters kolv satsades under kväve 500 ml metanol och 15,4 g (0,051 mol Åfbdium-(cyklo-oktadien-4,5)klorid]ë. 50,5 g (98 %, 0,12 mol) metyloyklohexyl-o-anisylfosfin sattes till lösningen och det hela omrördes i 1/2 timme, varigenom man erhöll en röd/orange lösning. Iösningen av natriumtetrafluor- borat (45,? g, 0,12 mol) i 160 ml vatten tillsattes under loppet av en timme. Orangefärgade kristaller avskiljde sig och uppsamlades. De tvättades med vatten (2x5O ml). Produk- ten torkades under vakuum vid 25°C och vägdes. Man erhöll på detta sätt 45 g produkt med en smältpunkt av 170-175°C. Detta material var till cirka 96 % optiskt rent.Example 22: Preparation of cyclooctadiene-4,5-bis (methylcyclohexyl-o-anisylphosphine) -rodium tetrafluoroborate. In a 4-liter flask was charged under nitrogen 500 ml of methanol and 15.4 g (0.051 mol of Abdium- (cyclooctadiene-4.5) chloride] 50.5 g (98%, 0.12 mol) of methyloyclohexyl chloride. o-Anisylphosphine was added to the solution and the whole was stirred for 1/2 hour to give a red / orange solution.The solution of sodium tetrafluoroborate (45 μg, 0.12 mol) in 160 ml of water was added over a period of Orange crystals separated and were collected, washed with water (2 x 50 ml) The product was dried under vacuum at 25 ° C and weighed to give 45 g of product with a melting point of 170-175 ° C. material was approximately 96% optically pure.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3647170A | 1970-05-11 | 1970-05-11 | |
US12211671A | 1971-03-08 | 1971-03-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7900355L SE7900355L (en) | 1979-01-15 |
SE430220B true SE430220B (en) | 1983-10-31 |
Family
ID=26713195
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7106040A SE400552B (en) | 1970-05-11 | 1971-05-10 | PROCEDURE FOR ASYMMETRIC HYDRATION OF A BETA-SUBSTITUTED ALFA ACYLAMINOACRYLIC ACID IN THE PRESENCE OF A CATALYST IN THE FORM OF A METAL COORDINATION COMPLEX IN COMBINATION WITH AN OPTICAL ACTIVE |
SE7409525A SE410463B (en) | 1970-05-11 | 1974-07-22 | METHYLYCLOHEXYL-O-ANISYLPHOSPHINE FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF OPTICALLY ACTIVE HYDRATION CATALYSTS |
SE7409524A SE412394B (en) | 1970-05-11 | 1974-07-22 | ASSOCIATION FOR APPLICATION AS A CATALYST AT THEY ASYMMETRIC HYDROGEN. |
SE7900355A SE430220B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
SE7900354A SE430219B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7106040A SE400552B (en) | 1970-05-11 | 1971-05-10 | PROCEDURE FOR ASYMMETRIC HYDRATION OF A BETA-SUBSTITUTED ALFA ACYLAMINOACRYLIC ACID IN THE PRESENCE OF A CATALYST IN THE FORM OF A METAL COORDINATION COMPLEX IN COMBINATION WITH AN OPTICAL ACTIVE |
SE7409525A SE410463B (en) | 1970-05-11 | 1974-07-22 | METHYLYCLOHEXYL-O-ANISYLPHOSPHINE FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF OPTICALLY ACTIVE HYDRATION CATALYSTS |
SE7409524A SE412394B (en) | 1970-05-11 | 1974-07-22 | ASSOCIATION FOR APPLICATION AS A CATALYST AT THEY ASYMMETRIC HYDROGEN. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7900354A SE430219B (en) | 1970-05-11 | 1979-01-15 | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF |
Country Status (16)
Country | Link |
---|---|
JP (1) | JPS5320011B1 (en) |
BE (1) | BE766960A (en) |
CA (1) | CA937573A (en) |
CH (1) | CH563346A5 (en) |
DE (1) | DE2123063C3 (en) |
FI (1) | FI55992C (en) |
FR (1) | FR2100644A1 (en) |
HU (1) | HU164803B (en) |
IL (1) | IL36804A (en) |
IT (1) | IT1019513B (en) |
NL (1) | NL155004B (en) |
NO (1) | NO142075C (en) |
RO (1) | RO80693A (en) |
SE (5) | SE400552B (en) |
SU (2) | SU640659A3 (en) |
YU (1) | YU35559B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4008281A (en) | 1973-12-03 | 1977-02-15 | Monsanto Company | Asymmetric catalysis |
US4376870A (en) * | 1980-12-05 | 1983-03-15 | Monsanto Company | Optically active phosphine compounds |
EP0077099A3 (en) * | 1981-10-08 | 1983-08-03 | ANIC S.p.A. | Process for preparing amino acids and their esters |
-
1971
- 1971-05-07 NL NL717106286A patent/NL155004B/en not_active IP Right Cessation
- 1971-05-10 JP JP3056471A patent/JPS5320011B1/ja active Pending
- 1971-05-10 FR FR7116805A patent/FR2100644A1/en active Granted
- 1971-05-10 SU SU711654953A patent/SU640659A3/en active
- 1971-05-10 IT IT24322/71A patent/IT1019513B/en active
- 1971-05-10 RO RO7166836A patent/RO80693A/en unknown
- 1971-05-10 IL IL36804A patent/IL36804A/en unknown
- 1971-05-10 DE DE2123063A patent/DE2123063C3/en not_active Expired
- 1971-05-10 BE BE766960A patent/BE766960A/en not_active IP Right Cessation
- 1971-05-10 SE SE7106040A patent/SE400552B/en unknown
- 1971-05-10 CH CH689171A patent/CH563346A5/xx not_active IP Right Cessation
- 1971-05-10 CA CA112638A patent/CA937573A/en not_active Expired
- 1971-05-10 HU HUMO793A patent/HU164803B/hu not_active IP Right Cessation
- 1971-05-10 NO NO1757/71A patent/NO142075C/en unknown
- 1971-05-10 FI FI1283/71A patent/FI55992C/en active
- 1971-05-11 YU YU1160/71A patent/YU35559B/en unknown
-
1974
- 1974-02-14 SU SU1995600A patent/SU526279A3/en active
- 1974-07-22 SE SE7409525A patent/SE410463B/en unknown
- 1974-07-22 SE SE7409524A patent/SE412394B/en unknown
-
1979
- 1979-01-15 SE SE7900355A patent/SE430220B/en unknown
- 1979-01-15 SE SE7900354A patent/SE430219B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SU526279A3 (en) | 1976-08-25 |
SE7900355L (en) | 1979-01-15 |
JPS5320011B1 (en) | 1978-06-24 |
SE7409524L (en) | 1974-07-22 |
YU116071A (en) | 1980-10-31 |
SE412394B (en) | 1980-03-03 |
SE430219B (en) | 1983-10-31 |
DE2123063A1 (en) | 1971-12-02 |
FR2100644A1 (en) | 1972-03-24 |
NO142075C (en) | 1980-06-25 |
CA937573A (en) | 1973-11-27 |
FR2100644B1 (en) | 1973-06-08 |
HU164803B (en) | 1974-04-11 |
SE410463B (en) | 1979-10-15 |
CH563346A5 (en) | 1975-06-30 |
FI55992C (en) | 1979-11-12 |
IL36804A (en) | 1978-06-15 |
BE766960A (en) | 1971-11-10 |
SE400552B (en) | 1978-04-03 |
IT1019513B (en) | 1977-11-30 |
RO80693A (en) | 1982-12-06 |
FI55992B (en) | 1979-07-31 |
IL36804A0 (en) | 1971-07-28 |
SE7409525L (en) | 1974-07-22 |
NO142075B (en) | 1980-03-17 |
NL155004B (en) | 1977-11-15 |
DE2123063C3 (en) | 1978-07-20 |
DE2123063B2 (en) | 1977-11-24 |
YU35559B (en) | 1981-04-30 |
SU640659A3 (en) | 1978-12-30 |
SE7900354L (en) | 1979-01-15 |
NL7106286A (en) | 1971-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU663273A3 (en) | Optically active catalyst for asymmetrical hydrogenation of substituted acrylic acids | |
Imamoto et al. | Synthesis and reactions of phosphine-boranes. Synthesis of new bidentate ligands with homochiral phosphine centers via optically pure phosphine-boranes | |
US3949000A (en) | Asymmetric diphosphines, their preparation and their use | |
EP0135392B1 (en) | Rhodium-phosphine complexes | |
ES2708693T3 (en) | Method for producing compound with carbonyl group using ruthenium-carbonyl complex having tridentate ligand as oxidation dehydrogenation catalyst | |
US4766225A (en) | Ruthenium-phosphine complex | |
US4604474A (en) | Rhodium-phosphine complex | |
CN101023092A (en) | Novel bisphosphane catalysts | |
US4124533A (en) | Metal coordination complexes containing optically active phosphine or arsine ligands | |
EP0271310B1 (en) | Ruthenium-phosphine complexes | |
Lo Schiavo et al. | Rhodium-palladium and rhodium-platinum heterobinuclear complexes containing the 2-(diphenylphosphino) pyridine short-bite bridging ligand. X-ray crystal structure of [(. eta. 5-C5H5)(CNBut) Rh (. mu.-Ph2PPy) Pd (CNBut) Cl] PF6 | |
JPH06506475A (en) | phosphorus compounds | |
EP0582668A1 (en) | Chiral tridentate bis(phospholane) ligands | |
US4261919A (en) | Catalytic asymmetric hydrogenation | |
EP0269395A2 (en) | Ruthenium-phosphine complex catalysts | |
US4265827A (en) | Catalytic asymmetric hydrogenation | |
US5103065A (en) | Transition metal complexes as catalysts for hydrogenation hydroformylation and cyclotrimerization | |
JP4201916B2 (en) | Optically active 1,2-bis (dialkylphosphino) benzene derivative, process for producing the same, and rhodium metal complex having the compound as a ligand | |
EP0015537B1 (en) | Process for the preparation of dienoic acids | |
SE430220B (en) | SUMMARY OF USE AS A CATALYST FOR ASYMMETRIC HYDRATION OF BETA-SUBSTITUTED ALFA ACYLAMINOACRYL ACIDS AND / OR SALTS THEREOF | |
JPH0338258B2 (en) | ||
CN103797020B (en) | P chiral source organic phosphorus compounds | |
US4190595A (en) | Process for dehalogenating the metal-halide bond in a low valent group VIII metal halide complex | |
US4294989A (en) | Methylcyclohexyl-O-anisylphosphine | |
George et al. | Reactions of silyl-and germyllithium compounds with azoxybenzene |